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Membrane lipid therapyThe classic heat shock (stress) response (HSR) was originally attributed to protein denaturation. However,
heat shock protein (Hsp) induction occurs in many circumstances where no protein denaturation is ob-
served. Recently considerable evidence has been accumulated to the favor of the “Membrane Sensor Hy-
pothesis” which predicts that the level of Hsps can be changed as a result of alterations to the plasma
membrane. This is especially pertinent to mild heat shock, such as occurs in fever. In this condition the sen-
sitivity of many transient receptor potential (TRP) channels is particularly notable. Small temperature
stresses can modulate TRP gating signiﬁcantly and this is inﬂuenced by lipids. In addition, stress hormones
often modify plasma membrane structure and function and thus initiate a cascade of events, which may af-
fect HSR. The major transactivator heat shock factor-1 integrates the signals originating from the plasma
membrane and orchestrates the expression of individual heat shock genes. We describe how these observa-
tions can be tested at the molecular level, for example, with the use of membrane perturbers and through
computational calculations. An important fact which now starts to be addressed is that membranes are
not homogeneous nor do all cells react identically. Lipidomics and cell proﬁling are beginning to address
the above two points. Finally, we observe that a deregulated HSR is found in a large number of important
diseases where more detailed knowledge of the molecular mechanisms involved may offer timelyhen; aSMase, acid sphingomyelinase; ATP, adenosine triphosphate; BA, benzyl alcohol; BM, bimoclomol; CaMKII, calmodulin ki-
CHOL, cholesterol; CRA, crotonaldehyde; DAG, diacylglycerol; DMPC, 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPH, 1,6-
receptor; ERK1/2, extracellular-signal-regulated kinase; FRET, ﬂuorescence resonance energy transfer; GCS, glucosylceramide syn-
ceptor; GlcCer, glucosylceramide; GPI, glycophosphatidylinositol; GR, glucocorticoid receptor; GSK3, glycogen synthase kinase-3;
eat shock protein; HSR, heat shock response; IP3, inositol trisphosphate; LB, luria broth; Ld, liquid disordered; Lo, liquid ordered;
phosphatidylcholine; LPS, lysophosphatidylserine; MALDI, matrix-assisted laser desorption/ionization; MAPK, mitogen-activated
ecular dynamics; MPS, membrane physical state; mTOR, target of rapamycin; NADA, N-arachidonoyl-dopamine; NPN, 1-N-
(R)-3-hydroxybutyrate; PI3K, phosphatidylinositol-3-kinase; PI4P, phosphatidylinositol 4-phosphate; PIP2, phosphatidylinositol
phate; PKA, protein kinase A; PKC, protein kinase C; PLA2, phospholipase A2; PLC, phospholipase C; PLD, phospholipase D; POPC,
E, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine; S1P, sphingosine-1-phosphate; SFA, saturated fatty acids; SGT,
gomyelin; SPC, sphingosylphosphorylcholine; TIRF, total internal reﬂection ﬂuorescence; TOCCSL, Thinning Out Clusters while
ceptor potential channel; UFA, unsaturated fatty acids; YFP, yellow ﬂuorescent protein
erms of the Creative Commons Attribution-NonCommercial-No DerivativeWorks License, which permits non-commercial use,
he original author and source are credited.
ane Structure and Function: Relevance in the Cell's Physiology, Pathology and Therapy.
mistry, Biological Research Center, Hungarian Academy of Sciences, 6726-Szeged, Temesvari krt. 62, Hungary.
hu (L. Vigh).
lished by Elsevier B.V. All rights reserved.
Cell-to-cell heterogeneity
Lipidomics
1595Z. Török et al. / Biochimica et Biophysica Acta 1838 (2014) 1594–1618opportunities for clinical interventions and new, innovative drug treatments. This article is part of a Special Issue
entitled: Membrane Structure and Function: Relevance in the Cell's Physiology, Pathology and Therapy.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.Membrane lipid therapyContents1. Introduction: new insights into the mechanism of heat shock response activation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1595
2. Evidence on structural changes in the plasma membrane during fever-type heat shock . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1596
3. TRP channels and temperature transduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1597
3.1. Modulation of TRP channels by lipids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1598
4. Stress hormones and the membrane-regulated stress response: heat shock can alter membranes indirectly through the elevation of
plasma glucocorticoid levels . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1599
5. Mimicking the effect of high temperature and the mode of action of membrane-perturbing Hsp inducers by computational techniques . . . . . . 1600
5.1. Effects of membrane perturber Hsp inducers: benzyl alcohol, phenethyl alcohol and bimoclomol . . . . . . . . . . . . . . . . . . . . 1601
6. Cell proﬁling and lipidomics: novel tools to explore the primary membrane-associated events critical in the triggering of stress signals . . . . . . . 1602
6.1. Background of cell population heterogeneity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1602
6.2. Heterogeneous cellular stress response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1603
6.3. Cell to cell variation of membrane heterogeneity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1605
6.4. “Zooming in” on membrane hyperstructures engaged in the generation of stress signal . . . . . . . . . . . . . . . . . . . . . . . . 1605
6.5. Lipidomics of the heat shock response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1605
7. Bridging the gap between plasma membranes and heat shock genes: Heat Shock Factor 1 at the crossroad . . . . . . . . . . . . . . . . . . . 1606
7.1. Hsp expression is regulated by HSFs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1606
7.2. HSF1: a central hub of membrane-mediated stress signaling . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1606
7.3. Plasma membrane modiﬁcations can modulate HSF1 activity in the absence of stress . . . . . . . . . . . . . . . . . . . . . . . 1607
7.3.1. Plasma membrane ﬂuidization by benzyl alcohol activates HSF1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1608
7.3.2. Plasma membrane lipid raft intercalating compounds modulate HSF1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1608
8. Genetic modiﬁcation of a pathogen's membrane physical state alters the heat shock response and causes loss of virulence of
Salmonella Typhimurium LT2 and Histoplasma capsulatum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1608
8.1. Effects of expression of heterologous Synechocystis Δ12-desaturase on membrane physical state of S. typhimurium . . . . . . . . . . . . . 1608
8.2. Attenuation of virulence, membrane ﬂuid state and heat shock response of H. capsulatum . . . . . . . . . . . . . . . . . . . . . . . . 1609
8.3. H. capsulatum Hsp70 gene expression, MΦ and mouse infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1609
9. From bench to bedside: therapeutic applications of heat shock protein-modifying agents . . . . . . . . . . . . . . . . . . . . . . . . . . . 1610
10. Concluding remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1611
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1612
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16121. Introduction: new insights into the mechanism of heat shock
response activation
All organisms can be exposed to environmentally-imposed stressors
such as elevated temperatures or UVB irradiation, physiological
stressors such as rapid cellular proliferation, or pathophysiological
stressors caused by infection or inﬂammation. Even normal develop-
mental or nutritional changes exert stress as systems temporarily depart
from and try to re-establish homeostasis. Responsiveness to diverse
stressorsmay arise from themost striking and common impact of stress:
it deforms andmaydamage the cell constituentmolecules suchasmem-
brane lipids, proteins or nucleic acids [1]. If unmitigated, such stressful
conditions lead – among others – to proteinmisfolding and aggregation,
membrane remodeling and raft disruption, cellular dysfunction and cell
death. Universally-conserved stress proteins can be regarded as the
minimal stress proteome. Functional analysis of theminimal stress pro-
teome is the best source to point for the major aspects of cellular stress
response. Hsps were ﬁrst identiﬁed as protectors of the integrity of pro-
teins and as guardians of the cell against stress. The cytoprotective func-
tions of these Hsps rest upon more than one molecular function;
protection from stress requires molecular chaperone activity to block
and repair protein unfolding aswell as speciﬁc inhibition of effector pro-
teins in the programmed cell death pathways, capabilities embedded
within the sequences of Hsps [2]. More recently –with active participa-
tion of our laboratories – these proteins were shown to possess a third
function, which is to migrate away from the “canonic” intracellular
sites of action to novel locations including the plasma membrane,
inner lysosomal membrane or even the extracellular compartments [3].Due to their multiple and vital functions, Hsps play a fundamen-
tal role in the pathology of several human diseases. Aberrantly high
levels of certain Hsp classes are characteristic in cancer cells and the
converse situation applies typically for aging, type 2 diabetes or for
many neurodegenerative diseases. Accordingly, the mechanism of
how stress conditions (including pathophysiological states) can be
sensed and transduced to regulate the expression of Hsp-genes is
of key importance [4].
Sincemanyof the stressors are believed to cause the accumulation of
abnormal proteins, sensing high temperature has been attributed in the
pastmostly to the denaturation of thermolabile proteins. But our studies
(and recently others, as well) strongly suggest that cells have the ability
to sense and respond to stress signals also through the activation of
membrane-associated signal transduction pathways. In our 1998 article
for Trends in Biochemical Sciences, we ﬁrst discussed how the
membrane's physical state could inﬂuence gene expression and,
hence, responses to stress [5]. Since then, knowledge of the interactions
between the plasma membrane and the gene-expressing machinery
has increased considerably, as has the realization that membranes dis-
play microheterogeneity. Our concept of the plasma membrane has
changed considerably as our understanding of membrane microdo-
mains and lipid rafts has increased [6]. Because the raft structure is
strongly dependent on the thermally-controlled lipid-phase behavior,
we assume that even mild changes in temperature could result in al-
tered ﬂuidity and consequently, redistribution and modiﬁed activity of
potential stress-sensing/signaling proteins within these subdomains.
The universal induction of cell stress response in most various organ-
isms (from bacteria and algae to yeast, plant and mammalian cells) by
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strongly suggests that subtle changes in the surface membranes are
the most upstream events of the temperature-sensing and signaling.
Network theory is increasingly becoming a prevailing paradigm to de-
scribe the diverse cellular functions under both normal and disease or
stressed states, as well. Hsp chaperones are known to form complex in-
teraction networks (the “chaperome”) with each other and their pro-
tein partners [7]. Obviously, this hierarchical cellular structure should
be further extended by acknowledging, that a subpopulation of Hsps
is temporarily or permanently membrane-associated and, that the indi-
vidual membrane lipid molecules can be active participants of the fold-
ing of membrane proteins [3].
Proof-of-principle examples are available for successful drug devel-
opment boosting components of the heat shock system and alleviating
disease. However, the efﬁcacy of these drugs is cell- and tissue-speciﬁc
as it depends on the context of existing, active and inactive signaling
pathways. Our ultimate focus is to develop membrane interacting sub-
stances (drugs acting on the base of “membrane lipid therapy”) to spe-
ciﬁcally target disease-relevant heat shock genes [8].
2. Evidence on structural changes in the plasma membrane during
fever-type heat shock
Recently, we made an interesting observation: when studying the
behavior of GPI-anchored proteins in the plasma membrane in living
Chinese hamster ovary (CHO) cells, we found that the proteins diffuse
as dimers, at least to a signiﬁcant extent (about 30%) [9]. The association
was extremely stable (over seconds), required thepresenceof cholester-
ol in the membrane, and showed a strong temperature-dependence. In
this paragraph, we provide our tentative interpretation of the observa-
tion, and discuss its links to the current literature.
Our approach is based on imaging single ﬂuorescently labeled pro-
tein molecules in the live cell plasma membrane. In general, the image
of a single dye molecule encodes its position (equivalent to the center
of mass of the signal distribution) and its brightness (the total number
of counts in the spot). In simple terms, n colocalized dye molecules
are n-times brighter than one molecule, therefore the brightness can
be used for determining the stoichiometry of a ﬂuorescently labeled
complex [10]. This approach works nicely for proteins at low surface
density in the plasma membrane, so that individual molecules can be
resolved as well-separated spots [11]. In most situations, however,
higher surface densities preclude a direct analysis.
For such cases we have devised amethod acronymed TOCCSL (Thin-
ning Out Clusters while Conserving the Stoichiometry of Labeling)
[12,13]. Brieﬂy, a strong laser is used to photobleach all ﬂuorophores
within a well-deﬁned area, so that complexes are either switched off
completely (within the photobleached area) or left intact (outside of
this area). Next, diffusional motion of the probe molecules leads to re-
covery of ﬂuorescence. At the very onset of this recovery process, the
ﬁrst protein molecules or complexes moving into the photobleached
area can be observed as well-separated ﬂuorescent spots. Fig. 1 shows
a typical TOCCSL experiment. The selected cell shows a uniform and ho-
mogeneous membrane staining (Fig. 1A,B). Immediately upon
photobleaching via a rectangular ﬁeld-stop, the ﬂuorescence signal is
completely erased within the selected area (Fig. 1C), and is slowly
repopulated from the edges of the ﬁeld-stop (Fig. 1D); in the center of
the area, individual spots are analyzed for their brightness.
In the referred study, wewere interested in the association behavior
of GPI-anchored proteins within the plasma membrane. When treating
cells with detergent, GPI-anchored proteins were described to partition
preferentially in the raft fraction [14–17], so we speculated that these
proteins may provide a route toward deciphering the enigmatic rafts
[6,18]. For that, we fused monomeric GFP [19] to the GPI-anchor of the
folate receptor [20] and expressed the construct in CHO cells. The
TOCCSL data revealed that about 20–40% of the observed spots
corresponded to mGFP-GPI dimers (Fig. 1E). Dimers were stable atleast over the time-scale of the experiment of a few seconds. Depleting
membrane cholesterol abolished the dimers completely. In addition, a
mild fever-type heat shock substantially reduced the dimer fraction
(Fig. 1F).
The data are surprising: the high stability of the complexes appears
unexpected for a lipid-mediated cohesion [21–23]. There are ideas
that the coupling to actin could stabilize per se transient clusters by pin-
ning them to the cortical cytoskeleton [21,23,24]; the clusters observed
in our experiments, however, were highly mobile (diffusion constant
D ~ 1.3 μm2/s) and therefore cannot be explained solely by interactions
with the cytoskeleton. Indeed, our observations are in line with obser-
vations of other researchers. For example, the lab of Kusumi reported
the formation of homodimers of GPI-anchored proteins, which could
be directly followed by single molecule tracking [25]. From studying
various chimeras, the interactions could be ascribed to contributions
both from the lipid-environment and the protein ectodomains,
resulting in a lifetime of the protein complexes of ~200 ms, somewhat
shorter than in our study.
It is quite enlightening to follow up on the idea of multiple contribu-
tions to the binding process. Let us consider here the following simple
binding reaction:
Aþ B
kþ
⇌
k−
A  B
kon
⇌
koff
AB:
A and B denote the two binding partnerswhichﬁrst form anencoun-
ter complex A ⋅ B, before the reaction proceeds to the bound complex
AB. k+, kon, k−, and koff describe the forward and backward rate con-
stants (here all in units of s−1). The two-dimensional diffusion-limited
rate for molecule A to collide with molecule B can be estimated by
kþ ¼ 2πcB
DA
ln
1
r
ﬃﬃﬃﬃﬃﬃﬃ
πcB
p
 þ DB
ln
1
r
ﬃﬃﬃﬃﬃﬃﬃ
πcA
p
 
2
664
3
775
where DA and DB denote the diffusion coefﬁcients, cA and cB the surface
densities of substance A and B, and r the radius of the encounter complex
[26,27]. The rate for dissolution of the encounter complex is given by
k− = 2[DA + DB]/r2 [28]. For this two-stage reaction, the overall equilib-
rium is characterized by the constant Ktotal ¼ kþk− 
kon
koff
¼ Kencounter  Kbinding;
the two stages – formation of the encounter complex and binding – can
therefore be factorized.
Next, two interacting proteins generally consist of multiple bind-
ing motifs, each contributing with ΔGi to the total interaction energy
ΔGbinding ¼∑
i
ΔGi. This converts to a product when calculating equi-
librium constants Kbinding ¼∏
i
Ki , with Ki ¼ exp − ΔGiRT
 
, R denoting
the gas constant, T the temperature. In other words, the full binding
process can be described by a product of equilibrium constants.
For simplicity, we consider here the three main contributions to the
interaction of two GPI-anchored proteins: the encounter complex for-
mation Kencounter, the protein ectodomain Kectodomain, and the lipid envi-
ronment Klipid, with Kbinding = Kectodomain ⋅ Klipid. A few conclusions can
be drawn immediately:
• Membrane-anchorage allows for oligomerization of ectodomains with
low interaction energy. Due to the high k+ in two dimensions, the for-
mation of encounter complexes is favored (Kencounter becomes large).
In addition, the lipid environment can contribute by stabilizing the in-
teraction (Klipid may get large). Finally, the limited rotational mobility
of membrane proteins can further increase kon [29].
• Multiple parameters may modulate the interaction. There are indica-
tions that the natural plasma membrane shows phase separation
into nanoscopic liquid ordered (Lo) and liquid disordered (Ld)
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one of the two phases will therefore yield a higher surface density
within the preferred phase, when compared to a uniform distribu-
tion of the protein. For our case of a GPI-anchored protein, prefer-
ential lo-phase partitioning will raise the local surface density of
the GPI-protein; consequentially, k+ and thus Kencounter will be
high. The lower diffusion constants within the Lo phase will hardly
affect the binding equilibria, as they reduce on- and off-rate pro-
portionally. In addition, the local lipid composition within the pre-
ferred Lo phase may alter the binding reaction directly via ΔGlipid.
For example, locally increased cholesterol and ganglioside GM1
concentration in the Lo phase [32] may assist in the stabilization
of complexes of GPI-anchored proteins.
Let us summarize these thoughts in view of a cell's capability to
sense temperature. First, it is highly plausible that lipidmembranes gen-
erally act as sensors for changes in the environment, which affect Ktotal
by changed equilibria of membrane protein interactions. Changed pro-
tein interactions would naturally inﬂuence a variety of signaling path-
ways that involve cell surface receptors. Second, temperature, in
particular, has a strong inﬂuence on membrane properties such as the
phase state of multi-component mixtures. Plasma membrane vesicles,
for example, phase-separate into micrometer-sized Lo–Ld coexistence
regions at room temperature, which shrink to nanoscopic domains of
ﬂuctuating size at physiological temperature [33]. Third, temperature-Fig. 1. Temperature elevation releasesmGFP-GPI homo-association in the plasmamembrane of
light image and the ﬂuorescent image of amGFP-GPI-expressing CHO cell. The box indicates the
protocol. The upper panels present the original data; the lower panels present a sketch of the e
and white dots, respectively. The white hatched areas indicate the position of the ﬁeld stop
photobleached by a laser pulse (450 ms). The efﬁciency of photobleaching was controlled by
the ﬁrst ﬂuorescent spots entering the ﬁeld of view could be observed as diffraction-limited s
data point resulted from the analysis of a single cell. Experiments are shown under standard con
were performed at indicated temperatures and dimer fractionswere determined by pooling dat
the temperature from 37 °C to 39 °C. At 41 °CmGFP-GPI homo-association was hardly detectab
for Biochemistry and Molecular Biology.”dependent nanoscopic rafts may thus stabilize interactions of GPI-
anchored or other membrane proteins by increasing Kencounter and Klipid.
A rise in temperature would result in the disassembly of rafts, and in a
homogeneous distribution of the membrane proteins. Consequentially,
Kencounter and Klipid will be lowered, resulting in a decreased binding
rate of the membrane proteins — as observed in our study (Fig. 1F).3. TRP channels and temperature transduction
Transient receptor potential (TRP) channels constitute a large family
of cationic channels. First identiﬁed in Drosophila (reviewed by [34]),
TRP channels play important roles in sensory physiology, including
the transduction of chemical, temperature and mechanical stimuli
[35,36]. Many TRP channels act as polymodal transducers, responding
to different forms of energy, as a result of cooperative allosteric interac-
tions in their gating [37].
Several TRP channels are expressed in terminals of primary sensory
neurons covering the skin and mucosa lining the surface of the body
(cornea, mouth, nasal epithelium). Here, they can be exposed to rapid
temperature ﬂuctuations. In regard to temperature sensing, some TRP
channels show remarkable temperature sensitivity, with temperature
coefﬁcient (Q10) values larger than 20 [38,39], compared to values be-
tween 1 and 3 which are typical for other proteins. Their activation re-
sults in local depolarisations and the generation of action potentialsliving CHO cells. The principle of the TOCCSLmethod is shown in A–D. A, overlay of a white
region of interest chosen for the TOCCSL sequence. B–D, different steps of the illumination
ffect on protein oligomers. Active and photobleached ﬂuorophores are indicated by green
(width of 7 μm). After recording the pre-bleach image (B), the selected area was totally
an image recorded immediately after the bleach pulse. After a recovery time of 800 ms,
ignals. E, the dimer fraction as a function of the mGFP-GPI surface density at 37 °C. Each
ditions (black circles) or after cholesterol depletion (red symbols). F, TOCCSL experiments
a frommultiple cells.We found a substantial decline of the dimer fractionwhen increasing
le. Scale bars: 5 μm. “This research was originally published in [9]. © the American Society
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conscious homeostatic responses (reviewed by [40]). Some TRP chan-
nels, TRPV1, TRPV2, TRPV3, TRPV4 and TRPM3, are gated bywarm tem-
peratures, while others, TRPM8 and TRPA1, are gated by cooling.
Collectively, TRP channels cover the entire range of physiological rele-
vant temperatures, from the extreme cold to harmful heat stimuli.
TRPV1 was the ﬁrst mammalian TRP channel identiﬁed [41]. It is
expressed in nociceptors and is gated by heat, low pH, capsaicin and en-
dogenous lipids, playing a critical role in inﬂammatory pain and heat
hyperalgesia [42]. Several recent reviews provide detailed information
about the biophysical properties and physiological roles of TRP channels
gated by temperature [35,40,43].
The molecular mechanism underlying temperature sensitivity of
TRP channels is still unknown. The scarce structural information
about these channels is currently a limiting factor in addressing this
question. In the case of TRPV4, heat sensitivity appears to be mediated
by the generation of an intracellular soluble ligand [44]. Also, it has
been hypothesized that some TRP channels might sense temperature-
mediated changes in lipid bilayer tension [36,39]. Other studies sug-
gested that TRPV1 may be gated by heat indirectly, following the pro-
duction of endogenous metabolites of linoleic acid [45]. However,
puriﬁed TRPV1 channels reconstituted in artiﬁcial liposomes show in-
trinsic heat sensitivity that is unaffected by changes in bilayer tension
[46]. Structural domains involved in heat sensing of TRPV1 are still
uncertain but some results with chimeric channels implicate the intra-
cellular C terminus [47]. In fact, Clapham and Miller postulate the
participation of a large number of hydrophobic groups in the conforma-
tional changes taking place during temperature activation of TRP chan-
nels [48].
TRPM8 channels can be gated by cold temperature in artiﬁcial lipid
bilayers, suggesting an intrinsic cold sensitivity [49]. A direct comparison
of temperature sensitivity of TRPM8 channels expressed in recombinant
systemswith the sensitivity of the same proteins in native tissues has re-
vealed important shifts in their absolute threshold [50]. These differences
suggest that native channels may be modiﬁed by post-translational
modiﬁcations (e.g. phosphorylation) or by interaction with auxiliary
proteins. Very little is known about the interactome of speciﬁc TRP chan-
nels. Recent studies have identiﬁed proteins interacting with TRP chan-
nels and modulating their thermal sensitivity. These include Pirt, an
integral membrane protein that modulates TRPV1 [51] and TRPM8
[52]. In the case of TRPM8, several post-translational modiﬁcations
have been shown to modulate the activity of the channel. Thus, several
studies indicate that TRPM8 is modiﬁed by N-glycosylation at a single
residue near the extracellular mouth of the channel pore [53–55]. A de-
tailed characterization of mutant channels, or wildtype channels treated
with tunicamycin, showed that these channels had normal trafﬁcking to
the plasmamembrane but that their temperature-dependent gatingwas
impaired [54]. Recently, a covalent linkage of large polymeric chains of
poly-(R)-3-hydroxybutyrate (PHB) to TRPM8 was reported [56].
TRPM8 mutants lacking speciﬁc PHB-binding sites, and wildtype chan-
nels treated with PhaZ7, a PHB depolymerase with serine hydrolase ac-
tivity, showed strongly reduced activity to menthol or cooling. The
authors postulated that the large PHB polymer subunits will stiffen or
contract with low temperatures, leading to strong conformational rear-
rangement of the TRPM8 protein. The changes in PHB conformation
could lead to alterations in the protein followed by channel opening. Ser-
ine residues in the S3–S4 extracellular linker are critical in supporting
PHB interaction and gating.
3.1. Modulation of TRP channels by lipids
Lipids exert important modulatory roles on many classes of ion
channels, and TRP channels in particular (reviewed by [57,58]). Lipid
composition of neuronal membranes is varied and non-uniform. This
heterogeneity, including lipids with varying degrees of unsaturation,
different head group structures and different acyl chains is acomplicating factor when analyzing the effects of speciﬁc lipids on
TRP channels. In addition, some cellular membranes are strongly com-
partmentalized, facilitating rapid local variations in the concentration
of speciﬁc lipids. Besides composition, other factors affect the physical
properties of lipid membranes, most notably temperature (see
Section 2). Thermodynamic changes in the lipid matrix surrounding
the channels can also inﬂuence their gating behavior. The most direct
way of assessing the effects of lipids on ion channels is to reconstitute
puriﬁed proteins into membranes of deﬁned composition, like artiﬁcial
liposomes [46] of synthetic lipid bilayers [49,59]. Lipids known tomod-
ulate TRP channels include: membrane phosphoinositides,
lysophospholipids and lysophosphatidic acid (LPA), cholesterol, linoleic
acid, anandamide, lipoxygenase and cyclooxygenase metabolites of ar-
achidonic acid (AA). Some active lipids are produced endogenously. In
the next paragraphs we highlight the modulation of some thermally-
sensitive TRP channels by lipids.
The importance of phosphatidylinositol 4,5-bisphosphate (PIP2) in
cell signaling derives from the fact that it is relatively abundant in the
membrane and because it is the substrate for phospholipase C (PLC),
leading to regulated ﬂuctuations in the concentration of PIP2 by activa-
tion of cell surface receptors [60]. Many TRP channels are sensitive to
PIP2 (reviewed by [58,61]). However, this modulation is complex and
controversial in the case of speciﬁc channels (e.g. TRPV1). For most
TRP channels (e.g. TRPM8 and TRPV5/6), gating depends on the
presence of PIP2 in the plasma membrane (reviewed by [62]). In the
case of TRPM8, activity runs down in excised patches and recovers
with perfusion of PIP2 [49,63]. Similar results were obtained with chan-
nels reconstituted on lipid bilayers [59,64]. Other pharmacological or
enzymaticmanipulations of PIP2 levels are consistentwith an activating
role on TRPM8 [65]. PIP2 can also play a role in regulating the desensiti-
zation of the channel. Consistent with this scenario, PIP2 depletion
resulting of the activity of Gq/11-PLC-coupled receptors leads to inhibi-
tion of TRPM8, although one study indicates a direct inhibitory effect of
Gα protein subunits on the channel [66].
The regulation of TRPV1 by PIP2 appears to be more complex. Re-
cently, Cao and colleagues investigated the modulation of puriﬁed
TRPV1 by phosphoinositides in artiﬁcial liposomes. The authors con-
vincingly showed that gating of TRPV1 by agonists, including tempera-
ture, does not require phosphoinositides [46]. Moreover, several
phosphoinositides (PIP2, PI4P) inhibited TRPV1 activity tonically. The
interaction of TRPV1 with phosphoinositides was traced to the intracel-
lular C terminus [46,67]. In contrast to these results, several other stud-
ies have shown that application of PIP2 can activate TRPV1 channels in
excised patches [68]. Finally, others have described dual effects of PIP2
(partial inhibition and activation) depending on channel state [69].
Clearly, more studies are needed to sort out these differences.
Linoleic acid is an unsaturated omega-6 fatty acid with an 18 carbon
chain, used in the synthesis of AA. Oxidized products of linoleic acid,
produced endogenously during inﬂammation and tissue injury, are po-
tent stimulators of TRPV1. In contrast, these products are inactive on
TRPV2/3/4 [45].
Lysophospholipids, speciﬁcally lysophosphatidylcholine (LPC) and
lysophosphatidylserine (LPS), activate TRPM8 and sensitize responses
to cold temperature [70,71]. These lipids are generated by calcium-
independent PLA2 activity. These lysophospholipids are conically
shaped, changing membrane curvature when inserted asymmetrically.
On the basis of interactions between LPC and cationic amphipaths
(e.g. tetracaine and chlorpromazine), the authors postulated local
changes in bilayer tension as determinants of lysophospholipid effects
on TRPM8. Similarly, other compounds partitioning in the lipid bilayer,
such as volatile anesthetics (e.g. halothane, chloroform), also modulate
TRPM8 activity [72]. Interestingly, LPC does not activate TRPV1 [73]. In
contrast, LPA, an enzymatic product of lysophospholipids, produced in
great amounts during tissue injury, activates TRPV1 channels directly
by binding to a positively charged amino acid (Lys710) on the C termi-
nus [73]. LPA was ineffective on TRPV2/3 and TRPA1. Because the
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an efﬁcient transbilayer movement of the molecule.
The endocannabinoids N-arachidonoyl-ethanolamide (ananda-
mide) and N-arachidonoyl-dopamine (NADA) [57,74,75] activate
TRPV1. Anandamide binds to TRPV1with relatively low afﬁnity and po-
tency. In contrast to the activating effects on TRPV1, anandamide and
NADA inhibit TRPM8 activity [75]. Consistent with this ﬁnding, several
plant-derived cannabinoids including cannabidiol, cannabidiol acid,
cannabigerol, Δ9-tetrahydrocannabinol, and Δ9-tetrahydrocannabinol
acid, also inhibit menthol- and icilin-evoked Ca2+ increases in TRPM8
expressing cells with IC50-values in the submicromolar range [75].
Other endogenous lipids activating TRPV1 include lipoxygenaseme-
tabolites of AA, in particular 12-(S)-hydroperoxyeicosatetraenoyl acid
(12-(S)-HPETE), 5-(S)-hydroxyeicosatetraenoyl acid (5-(S)HETE), and
leukotriene B4 (LTB4) [76]. Farnesyl pyrophosphate, an isoprene lipid
in the cholesterol synthesis pathway, activates TRPV3 [77] without ef-
fects on TRPV1 [73].
Cholesterol is an essential lipid in the plasma membrane of eukary-
otic cells. Lipid-rafts are lateral membrane microdomains enriched in
cholesterol and sphingolipids [18,78]. The activity of some TRP channels
(e.g. TRPV1 and TRPC3) is sensitive to membrane cholesterol content,
suggesting that raft association is pivotal for the physiological role of
these channels. In addition, lipid rafts can compartmentalize ion chan-
nels and other signaling proteins [79]. Several TRP channels have been
shown to segregate into cholesterol-rich lipid microdomains including
TRPC1, TRPC3, TRPC4 and TRPC5 and TRPM8 [80–82]. In the case of
TRPM8, lipid-raft disruption with methyl-β-cyclodextrin (MBCD) in-
creased both menthol- and cold-mediated activation. Moreover, the
threshold to activate TRPM8 shifted to higher temperatures when the
channels were displaced outside of lipid-rafts [81,83]. These results in-
dicate that the lipid-membrane environment modulates the properties
of TRPM8 channel as a cold sensor and suggests a role for lipid-rafts in
cold transduction.
Recently, an essential contribution of TRPV1 was demonstrated
in heat-inducible Hsp induction [84]. As such, it is tempting to spec-
ulate that TRPV receptors might form a new class of therapeutical
targets enabling us to modulate the HSR response. For example, by
inhibiting their activity, an overactive HSR – as seen in multiple
cancers – might be tempered subsequently potentiating the effect
of various chemotherapeutical strategies.
Taken together, lipids modulate the activity of thermally-gated TRP
channels by multiple mechanisms. In some cases, lipids exert direct ef-
fects on the channel, acting as allostericmodulators thatmodify the sen-
sitivity to other agonists (temperature, chemical agonists). In other
cases, the effects of lipids appear to be indirect, altering the mechanical
properties of the membrane, leading to gating of the channel. From the
functional point of view, direct and indirect effects are equally relevant
in shaping the response of TRP channels to environmental stimuli.
4. Stress hormones and the membrane-regulated stress response:
heat shock can alter membranes indirectly through the elevation of
plasma glucocorticoid levels
A coordinated neuroendocrine response ismounted following expo-
sure to a variety of environmental stressors, including temperature
changes, in order to minimize homeostatic disturbances [85]. The phys-
iological response to acute stress is relatively well conserved among
vertebrates and involves the rapid release of stress hormones, primarily
catecholamines and glucocorticoids. Once stress hormones are secreted
into the blood, they act on target tissues to stimulate physiological ad-
justments that allow the organism to cope with stress [86]. In addition
to receptor-mediated responses, stress hormones also interact with
plasma membrane lipid and protein components, resulting in varying
degrees of perturbations to the physicochemical properties of the plas-
ma membrane [87]. Since glucocorticoids diffuse through the plasma
membrane, biophysical alterations induced by this steroid are ofparticular interest. Moreover, glucocorticoids are traditionally associat-
ed with eliciting delayed effects by activating the glucocorticoid recep-
tor (GR) and the associated genomic signaling events; however, they
also elicit rapid cellular responses that are nongenomic [88]. Although
seldom investigated, the possibility exists that biophysical changes to
the plasma membrane are integral to non-genomic actions of steroids
[87].
Ectothermic organisms, in particular, are exposed to a greater range
of environmental disturbances and typically possess enhanced homeo-
static defenses [89]making them ideal organisms to studymembrane re-
sponses. Recently it was demonstrated that stressor-mediated elevation
in corticosteroid levels alter the ﬂuidity of liver plasma membrane, po-
tentially leading to modulation of signaling pathways in rainbow trout
[90,91]. This ﬁnding implicates the plasmamembrane as a potential reg-
ulator of stress hormone-mediated cellular effects and indicates that
stressors, including heat shock, can alter membranes by directly altering
intermolecular interactions, as well as indirectly through the elevation of
plasma glucocorticoid levels. In rainbow trout (Oncorhynchus mykiss),
cortisol signiﬁcantly ﬂuidizes hepatic plasma membrane in vitro at con-
centrations comparable to endogenous stress levels (100–1000 ng/ml)
[91]. The ﬂuidity changes seen with cortisol were not dose-dependent,
but instead occur at concentrations≥100 ng/ml, which are typical levels
observed in stressed salmonids [91]. The all-or-none response coupled
with the inability of an impermeable cortisol–peptide conjugate to
alter lipid order suggests a receptor-independent mechanism that de-
pends on steroid partitioning into the lipid bilayer [91]. In rat erythro-
cytes, corticosteroids were shown to have a greater impact on
membrane order near lipid–protein domains compared to regions de-
void of protein [92]. This underscores that microviscosity alterations
due to cortisol incorporation into lipid bilayer may play a fundamental
role in regulating signal transduction pathways, including stress-
activated cascades.
The ﬂuidity of the lipid environment also affects lipid raft formation
and stability [93]. Indeed, atomic force microscopy imaging, which mea-
sures surface properties of membranes, has revealed that cortisol alters
structural organization of membrane microdomains in rainbow trout
[91]. The physical perturbationsmediated by cortisol are not uniform be-
tween microdomains, as cortisol altered the surface adhesion of lower
membrane domains, but had a minimal effect on higher membrane do-
mains [91]. Membrane domain reorganization in response to cortisol
was also reported in rat erythrocytes and involved formationof large pro-
tein–lipid domains and changes inmembrane elasticity [92]. Other stress
hormones, including epinephrine andnorepinephrine, also altered eryth-
rocyte plasma membrane topography, further suggesting that physical
changes to the plasma membrane that are hormonally-mediated may
be important for mounting a cellular response to stressors. More impor-
tantly, while stress hormones increased membrane microviscosity of rat
erythrocytes, each had a distinct effect on microdomain formation sug-
gesting that biophysical alterations are hormone-speciﬁc [92], and
changes to membrane organization may play an important role by
which hormones coordinate and integrate cellular stress response.
Activation of the systemic physiological stress response and its effect
on biophysical alterations to the plasma membrane were recently
assessed in rainbow trout liver [90]. The experiment consisted of a
brief handling disturbance of rainbow trout injected with either saline
(sham) or metyrapone, an 11β-hydroxylase inhibitor that blocks en-
dogenous cortisol biosynthesis [94]. Interestingly, this study demon-
strated that a physical stressor eliciting a cortisol response was
sufﬁcient to rapidly ﬂuidize liver plasma membranes, and this was fur-
ther conﬁrmed by the absence of a stressor-effect onmembrane proper-
ties in the metyrapone group (Fig. 2). Changes in lipid order were
accompanied by an increase in membrane roughness, similar to those
seen with cortisol treatment in vitro [90]. This novel ﬁnding suggests
that cortisol incorporation into the lipid bilayer increases membrane
ﬂuidity in vivo, while the mechanisms remain to be elucidated [90].
Stressor-mediated microdomain reorganization likely has important
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regulating receptor activity and intracellular signaling [78]. Moreover,
raft-dependent signaling cascades are reportedly more sensitive to
membrane disturbances in the liver since hepatocytes lack caveolae,
which are stable membrane domains that are enriched with oligomeric
complexes of caveolin [95].
Stress hormones are also established regulators of the HSR [96]. In
response to thermal stress, cortisol facilitates mobilization of energy
stores tomeet the enhancedmetabolic demands during thermal distur-
bances. In addition to metabolic reprogramming, cortisol also regulates
the cellular stress response by attenuating the production of Hsps,
which likely helps to restrict excessive use of cellular energy needed
for de novo protein synthesis [97]. Currently, the mechanism by which
cortisol attenuates the HSR in teleosts is poorly understood but seems
to involve GR degradation by the proteasome [98]. In rainbow trout cor-
tisol ﬂuidizes liver plasmamembranes [90,91], therefore, onemight ex-
pect that cortisol would enhance, rather than attenuate, Hsp induction.
However, not all ﬂuidizing agents activate the HSR, and instead the
nanomolecular perturbations to microdomain structure likely deter-
mine the intracellular response [99]. Cortisol-induced biophysical alter-
ations are also accompanied by rapid and transient activation of stress-
activated kinase pathways, including ERK1/2, AKT, PKC and PKA (Fig. 3;
[90,91]). These stress-activated kinase pathways are also known to re-
spond to membrane perturbations (see further) [100,101], including
biophysical alterations mediated by benzyl alcohol (BA) in rainbow
trout liver [91]. Moreover, it has been demonstrated that phosphoryla-
tion by ERK1/2 and PKC leads to the suppression of HSF1 activity in
humans [102–104]. Although the role of phosphorylation in regulating
teleost HSF1 transcriptional activity is currently unknown, we propose
that the regulation of stress-activated kinases by cortisol-mediated
membrane perturbations may also play a role in the attenuation of the
HSR in ﬁsh.
Combined, there is mounting evidence for a novel membrane-
mediated stress adaptation response through direct perturbations
to the plasma membrane in response to stress hormones. The inter-
action of stress hormones with the plasma membrane signiﬁcantly
impacts membrane ﬂuidity and stimulates membrane microdomain
restructuring. The cortisol-mediated membrane restructuring is as-
sociated with enhanced phosphorylation of stress-activated pro-
teins, underscoring a functional role for this steroid in rapid stress
signaling and the overall cellular stress response.
5. Mimicking the effect of high temperature and the mode of action
ofmembrane-perturbingHsp inducers by computational techniques
Once the physical state of a membrane is modiﬁed, the membrane
permeability and/or the membrane protein activity may change. TheFig. 2. Effect of acute stress on1,6-diphenyl-1,3,5-hexatriene (DPH)ﬂuorescence anisotro-
py. DPH ﬂuorescence anisotropy (inversely related to membrane ﬂuidity) was measured
in enriched hepatic plasma membranes isolated from sham or metyrapone-treated trout
before and 30 min after a handling stress. Data representsmean ± S.E.M. (n = 4–6). Dif-
ferent upper case letters and inset indicate signiﬁcant time and treatment effects, respec-
tively (two-way ANOVA, p b 0.05). This ﬁgure was originally published in [90].complex interplay between chemical–physical membrane state and
cell membrane activities continues to be object of investigation. Zhang
et al. [105] and Rossignol et al. [106] studied the inﬂuence ofmembrane
ﬂuidity on the lysosomal permeability to H+ by ﬂuidizing and rigidify-
ing the membranes with BA and cholesteryl hemisuccinate, respective-
ly. They demonstrated that the increases or decreases in membrane
ﬂuidity correspond to the increases or decreases in their proton perme-
ability. Deamer andNichols [107] found that theproton permeation cor-
relates with the physical properties of the membranes and involves
transient formation of hydrogen bonded chains of water within the
membranes.
A small fraction of the water in the bilayer might be associated
through hydrogen bonding, thereby providing a proton conductive
pathway. The permeation of protons across membranes is suggested
as being along the hydrogen bonds of water, which crosses the mem-
branes through aqueous pores [108] and transient defects [109]. It has
been established that ﬂuidizing or rigidifying membranes can increase
or decrease the size of their aqueous pores, respectively [110], and
that the transient defects of membranes can be increased in number
by the temperature-dependent phase transitions or bymembrane ﬂuid-
izers. It should be noted that a number of studies ﬁnd little correlation
between membrane ﬂuidity and proton permeability for some mem-
branes [111,112]. These studies suggested that the effects of membrane
ﬂuidity and water permeability on the proton permeation are depen-
dent on the membrane types.
Recently, we [113] demonstrated a direct correlation between
the membrane ﬂuidization of the lipid region and the Hsp response
for mammalian cells. We chose BA and heptanol as membrane ﬂuid-
izers in model membranes to follow the idea that weakening the in-
teractions between lipid chains could induce a disordering effect in
membranes similar to the heat shock. The idea that the modiﬁcation
of the lateral lipid organization is responsible for membrane dys-
function is particularly attractive in the context of the lipid raft
model.
In mammalian cells, a thermal shift up to 42 °C triggers the HSR, ac-
companied by increases in the expression of genes for stress proteins
such as Hsp70. Similarly, the addition of small molecules capable to
act as membrane ﬂuidizers can induce a similar response [113]. The
most critical aspect of the term “ﬂuidity” is that it is not operationally
well deﬁned, since a bilayer is inherently anisotropic and the effect of
different ﬂuidizers can be observed in different portions of the mem-
brane [114].
Molecular dynamics (MD) is a computational technique that permits
to gain insight in the lipid environment without the use of bilayer-
perturbing probes. Unfortunately, until very recently, lipid molecules
were not well parameterized and the time length of the simulations,
usually less than 10 ns, precludes the observation of important phe-
nomena such as water permeation and raft evolution. In recent years,
several MD studies have been published to verify the effect of chemical
ﬂuidizers in membranes [8,115–118].
Here, we report a molecular dynamics study of 3 small molecule
heat shock protein inducers (BA, phenethyl alcohol (PhA), and
bimoclomol (BM)) all capable to perturbate lipid membranes simi-
larly to thermal stress [113,119]. The goal was to correlate their doc-
umented effects on the HSR with the differences in the interaction of
these molecules with 4 model membranes designed by computa-
tional modeling.
Four model membranes have been used as controls: two mem-
branes are made of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), re-
spectively. A third membrane was a mixture of POPC and 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) with molar ratio
1:1. The fourth membrane is made of sphingomyelin (SM) and choles-
terol (CHOL) in molar ratio 1:1. The ﬁrst three mixtures (POPC, DMPC,
POPE) model membranes in the Ld phase, while the fourth mixture
(SM/CHOL) represents lipid rafts in the Lo phase (see Box 1).
1601Z. Török et al. / Biochimica et Biophysica Acta 1838 (2014) 1594–16185.1. Effects of membrane perturber Hsp inducers: benzyl alcohol, phenethyl
alcohol and bimoclomol
In order to determine the mechanisms followed by BA, PhA and BM
administration to modulate membrane nanostructure and to compare
the differences obtained in respect of the thermal effect, we have per-
formed a molecular dynamics investigation of the three molecules in-
corporated in 4 membranes of different intrinsic ﬂuidity: POPC/POPE,
POPC, DMPC and SM/CHOL.
In Table 1 we indicated two of the most important structural
parameters: surface area per lipid and thickness of the bilayer. With-
in the approximation of the AMBER03 force ﬁeld, we obtained stable
membranes with values slightly smaller than those derived from ex-
perimental observations. Upon addition of the Hsp inducers we have
calculated the total potential energies after an equilibration run of
20 ns. The energies have been normalized on the molecular weight
to permit appropriate comparison. The main results are shown in
Table 2.
As a common feature, BA, PhA and BMmolecules show a clear ability
to penetrate the membrane. The distribution coefﬁcient at pH 7.4 of
PhA and BA is higher than the one of BM, indicating that the two alco-
hols are completely absorbed in lipid membranes, whereas BM distrib-
utes between lipid membranes and water. Even if the molecules are
initially placed in the bulk aqueous phase, the membranes quickly ab-
sorb BA and PhA. BM appears to be equally partitioned between water
and membranes.Fig. 3. Cortisol effect on rapid cell signaling in trout hepatocytes. Rainbow trout hepatocytes w
homogenates (40 μg protein) were probed with polyclonal rabbit antibody (Cell Signaling Tec
(RRXS/T) (B) or phospho-AKT substrate (RXXS/T) (C). Equal loading was conﬁrmed with β-ac
each is shown; values are plotted as % control and shown as mean ± S.E.M. (n = 3 indep
ANOVA, p b 0.05). *Signiﬁcantly different from control (Paired Student's t-test; p b 0.05). ThisInterestingly, BA and PhA stabilize the SM/CHOLbilayer, but increase
the energies in POPE/POPC, POPC and DMPCmembranes. BM acts in an
opposite manner: it causes stabilization of Ld membranes and remains
almost ineffective in Lo membranes. Apparently, BA and PhA, less
bulky, can better interact with SM molecules in SM/CHOL membranes.
Though BA and PhA span the inner core of the membranes, they prefer
to expose the hydroxyl group to themembrane/water interface. Within
the approximation of the AMBER force ﬁeld, BA and PhA show the same
potential energy variations in all tested membranes.
With an isoelectric point of 11.56, BM is positively charged at phys-
iological pH and is completely absorbed on negatively charged mem-
branes containing phosphoserine. Nevertheless, BM is also capable of
interactingwith neutral membranes, preferringmore ﬂuidmembranes,
whereas BA and PhA accumulate in cholesterol-containing bilayers,
with higher spacing among headgroups. The difference in potential en-
ergy depends on the balance between the dipole–dipole interactions
between compounds and membrane headgroups and in the packing
change of the lipids. Besides the internal ordering and conformation of
the lipid components, it is important to characterize a membrane in
terms of its lipid lateral organization. In the case of the POPC, the lateral
spacing between hydrophilic headgroups is higher because of the acyl
chain cis-double bond, which leads to increased hydration. Consequent-
ly, the lateral packing is weaker and the insertion of more bulky BM is
easier. In SM/CHOL membranes, cholesterol was found to increase the
number of holes in the polar region of bilayers and thus to lower the sol-
vation free energy for small molecules in this region. BM tends toere incubated either with cortisol (0, 100 or 1000 ng/ml) or BA (25 mM) for 10 min. Cell
hnology, Beverly, MA) to either phospho-(Ser) PKC substrate (A), phospho-PKA Substrate
tin (monoclonal mouse antibody; Sigma, St. Louis, MO). A representative immunoblot for
endent ﬁsh); bars with different letters are signiﬁcantly different (repeated measures
ﬁgure was originally published in [91].
1602 Z. Török et al. / Biochimica et Biophysica Acta 1838 (2014) 1594–1618localize behind the phosphorous atoms of the bilayers and it affects the
cholesterol alignment and the headgroup orientation. BA, PhA and,
more intensively, BM cause lateral disorder in lipid bilayers. Lo phases
display a certain degree of periodicity of their lipids in the plane of the
bilayer, whereas in Ld phases such organization is lost at very short dis-
tances. The lateral order in membranes was quantiﬁed by calculating
the pair density correlation functions (data not reported).
DMPC lipid acyl chains become less ordered in the presence of BA
and PhA. Since POPC and POPC/POPE membranes are already in the
ﬂuid phase at room temperature, the ﬂuidity changes are much smaller
than that observed in DMPC membranes. BA and PhA induced a
disordering effect by weakening the van der Waals interactions be-
tween the lipid acyl chains. BMhas a stronger effect on the lateral stressBox 1
The design of model membranes.
The POPCmembrane consisted in 98 POPCmolecules; the simula-
tion box dimensions were X = 120.0 Å, Y = 57.18 Å and
Z = 56.42 Å filled with 24 Cl− and Na+ counter ions and 8265
watermolecules. ThePOPC/POPE (60–40%)membrane consisted
in 58 POPC and 40 POPE molecules; the simulation box dimen-
sions were X = 109.4 Å, Y = 56.69 Å and Z = 53.79 Å filled
with 20 Cl− and Na+ counter ions and 7098 water molecules.
The SM/CHOL membrane is made of 135 SM and 137 CHOL mol-
ecules. The initial box dimensions were X = 73.79, Y = 104.61,
Z = 72.62, filled with 26 Na+ and Cl− counter ions and 10,498
water molecules. The DMPCmembrane is made of 72 DMPCmol-
ecules. The initial box dimensions were X = 99.60, Y = 42.46,
Z = 42.33, filled with 3590 water molecules. The coordinates
have been taken from a previous work on phosphatidylcholine
(PC) membrane [120]. The volumes of BA, PhA and BM are of
101.40 Å3, 116.22 Å3, and 264.43 Å3, respectively. Upon inser-
tion in the bilayers, the membranes have been further relaxed with
a steepest descend followed by a simulated annealing until the
maximum atomic speed was slower than 500 m/s. All the simula-
tions were performedwith the program YASARA [121] under NPT
ensemble at 310 K and 1 atm by coupling the system with a
Berendsen thermostat [122] and by controlling the pressure in
the manometer pressure control mode. The force field utilized
was the AMBER03 [123]. The geometry of the molecules was op-
timized by semi-empirical AM1 method using the COSMO solva-
tion model [124]. Partial atomic charges were calculated using
the same level of theory by the Mulliken point charge approach
[125]. Electrostatic interactions were calculated with a cutoff of
10.48 Å, and the long-range electrostatic interactions were han-
dled by the Particle Mesh Ewald (PME) [126] algorithm using a
sixth-order B-spline interpolation and a grid spacing of 1 Å. The
leap-frog algorithmwas used in all simulations with a 1.25 fs time
step for intramolecular forces and 2.5 fs time step for intermolecu-
lar forces and the equilibration periodwas of 2 ns. The lipid bilayers
were assembled and relaxed reducing the box dimension till the
van der Waals energy of the system starts to increase [120,127]
and the structural parameters of the membranes are comparable
to previously published experimental data [23]. To remove bumps
and correct the covalent geometry, all the systems were energy-
minimized. After removal of conformational stress by a short
steepest descent minimization, the procedure continued by simu-
lated annealing (time step 2 fs, atom velocities scaled down by
0.9 every 10 steps) until convergencewas reached, i.e. the energy
improved by less than 0.05 kJ/mol per atom during 200 steps. A
full description of the protocols is given in [8,127].proﬁle (data not reported) and therefore it can modify the protein
helix–helix interaction along with the overall ﬂuidity.
Mass density proﬁles provide information on the averaged displace-
ment of membrane lipids upon the insertion of an exogenousmolecule.
In Fig. 4 the density proﬁle of the Lo membrane SM/CHOL is indicated.
Fig. 4A shows the atom distribution of the pure membrane. This distri-
bution, with cholesterols toward the membrane surfaces and with the
hydroxyl group under the SM headgroups (the so called umbrella
model) is clearly modiﬁed upon addition of BA (Fig. 4B), PhA (Fig. 4C),
and especially of BM (Fig. 4D). BM binding to themembranes is capable
to cause the sinking of the cholesterol toward the middle of the mem-
branes, increasing themobility of the hydrophobic regions immediately
under the SM headgroups. These results show that BM reduces themo-
bility of SM headgroups and themobility of terminal carbons, but due to
its effect to displace cholesterol, it may increase the mobility of the
chains toward the middle of the bilayer.
In conclusion, the mechanism of action of BA and PhA is typical of
anesthetics, inwhichBA and PhA replacewatermolecules that normally
penetrate under the phosphorus atom level, decreasing lipid chain re-
pulsion and the order parameters. Contrarily, BM,which bears a positive
charge at pH 7.4, preferentially interacts with negatively chargedmem-
branes. With neutral membranes, BM can penetrate slightly under the
phosphorous levels and it is capable to stabilize membranes containing
nonbilayer forming lipids (Table 1).
6. Cell proﬁling and lipidomics: novel tools to explore the primary
membrane-associated events critical in the triggeringof stress signals
The study of the cellular stress response is of great importance to our
understanding of how cells respond and adapt to various changes in
their environments especially during different pathophysiological con-
ditions. Fundamental questions relate to whether all cells in a culture
(or in tissue) suffer the same consequence of an imposed stress and
whether they respond in the same manner. Knowledge about gene ex-
pression and cellular responses in cells is derived from analyses of pop-
ulations consisting of millions of cells. Although this approach provides
useful insights into average population responses, they do not provide
information on individual cells or subpopulations within cell cultures.
Data obtained by common methods can be misleading, especially if
the responses of cells are heterogeneous or if subpopulations exist.
Thus, using the classical biochemical, biophysical approaches, we are
potentially missing a large amount of data on cells in populations. For
this reason, it is necessary to record data from many individual cells so
as to acquire a statistically signiﬁcant sampling of cellular behavior
and dynamics. One of the most common techniques for this task is
ﬂow cytometry which allows multiple parameters on individual cells
to be obtained and these cells could also be sorted for further study
[128]. Flow cytometry, on the other hand, cannot follow the same indi-
vidual cells in time. This quest depends heavily on molecular imaging,
which shows when and where genetically or biochemically deﬁned
molecules, signals or processes appear, interact and disappear, in time
and space.With high-content cellular analysis, it is necessary to perform
high-throughput phenotype proﬁling, linking gene expression to bio-
chemical signaling pathways in the cell and, ultimately, to cell behavior.
By combining state-of-the-art ultrasensitive imaging techniques, ﬂow
cytometry and biochemical analysis we can gain insight into the hetero-
geneous cellular stress response.
6.1. Background of cell population heterogeneity
Cells within isogenic populations exhibit broad phenotypic varia-
tion. For experimental purposes, such variation is readily apparent in
phenotypes that are selectable. Almost any study that has used mea-
surements of % viability (or other similar parameter) and documented
an intermediate value (i.e. other than 0% or 100%) is indicative of cell-
to-cell variation. This nongenetic heterogeneity can be fundamental to
Table 1
Comparison of structural parameters derived from experimental observations and molecular dynamics simulations after 50 ns.
Membrane composition Surface area per lipid (Å2) Average thickness of the lipid bilayer (Å)
Experimental Molecular dynamics Experimental Molecular dynamics
DMPC 61.7 61.1 35.7 33.1
POPC 69.5 68.9 39 35.3
POPE/POPC (50:50) 56.6–69.5 56.5–68.9 40 36.5
SM/CHOL (50:50) 49.5–29.6 49.2–28.3 42 38.8
Standard deviations were 0.5 Å2 and 0.3 Å2 for surface area per lipid and average thickness of the bilayer, respectively.
Experimental values are from: http://www.brocku.ca/researchers/peter_rand/lipid/default.html.
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erogeneity. The termpersistence is used to describe theminority of cells
within a genetically homogeneous microbial population that is able to
survive a period of antibiotic treatment. Phenotypic persister cells
were ﬁrst reported over 60 years ago. In 1944, Joseph Bigger noticed
that the newly-introduced penicillin was unable to “sterilize” a culture
of Staphylococcus [129]. His experiments indicated that persisters were
not mutants, and upon reinoculation produced a population containing
a sensitive bulk and new tolerant cells. The result clearly showed that
surviving persisters regenerate the original population, and are there-
fore phenotypic variants of the wild type. Similar phenomena have
now been documented in microorganisms exposed to a wide range of
antibiotics and other toxic agents (reviewed by [130]).
While microbial heterogeneity is well documented in both natural
and laboratory environments, the underlying causes are less well un-
derstood. The cell cycle, cell aging and epigenetic regulation are proven
drivers of heterogeneity in several of the best-known phenotypic exam-
ples. However, the full contribution of factors such as stochastic gene
expression is yet to be realized.
The available cell population heterogeneity studies in mammalian
cells are limited. A cell-to-cell variability in lipid droplet formation
was described as depending on the cascade responses of an insulin sig-
naling pathway which includes insulin sensitivity, kinase activity, glu-
cose import, expression of an insulin degradation enzyme, and insulin
degradation rate. Increased and prolonged insulin stimulation promotes
lipid droplet accumulation in all differentiating cells. Single-cell proﬁl-
ing revealed the kinetics of an insulin signaling cascade as the origin
of phenotypic variability in drug-inducible adipogenesis [131]. A recent
study of transcription activation in a serum starvation assay highlighted
the wide variety of responses among individual cells, even though the
large differences between the control and treatment groups were
scored in a population assay such as an immunoblot [132].
6.2. Heterogeneous cellular stress response
Heterogeneous stress resistance is widely documented in reports
dealing with virtually any stressor–microorganism combination. Such
heterogeneous resistance can be conﬁrmed to be non-inheritableTable 2
Effect of membrane perturber Hsp inducers on the total potential energies of different membr
Membranes Membrane potential energies (kcal/mol)
Pure BA PhA
POPE/POPC 8704
(119)
9076
(137)
9070
(129)
POPC 11,216
(121)
11,547
(137)
11,560
(140)
DMPC 9086
(148)
9458
(129)
9505
(130)
SM/CHOL 16,827
(125)
16,234
(134)
16,237
(138)
Energies are calculated on the basis of AMBER03 force ﬁeld. The values have been normalized o
brackets) is the standard deviation of energy values calculated every 0.5 ns in the last 5 ns of s(that is, non-genotypic), as has been shown for acid-stress and
osmotic-stress resistance in Escherichia coli [133]; and for sorbic-acid
[134] and heat resistance [135] in Saccharomyces cerevisiae. Analysis of
stress responses in single yeast cells revealed a remarkable variability
among individual cells in clonal populations (reviewed by [136]). Al-
though mean gene expression was affected by genetic background,
the heterogeneity of gene expression among individual cells in clonal
populations was described to reﬂect physiological differences between
cells like different stages of cell cycle or replication, or exposure to dif-
ferent local microenvironments.
The chaperoneHsp90 is reported to also function as an ‘evolutionary
capacitor’, suppressing the expression of genotypic variation in a
population [137]. It is proposed that the susceptibility of this capacitor
function to environmental perturbation serves to promote genotypic
heterogeneity when it is most likely to be advantageous to the organ-
ism. This premise has been extended to non-genotypic heterogeneity.
From modeling studies with yeast, it was suggested that a multitude
of cellular gene productsmight function like capacitors by buffering var-
iable expression of other genes in gene-regulatory networks [138] In ad-
dition to the above roles, Hsps can inﬂuence cellular stress resistance
directly. Evidence for single-cell variability in this regard has come
from in situ studies using RT-PCR in Salmonella enterica serovar
Typhimurium, in which the levels of mRNA for the Hsp GroEL displayed
signiﬁcant heterogeneity between individual cells [139]. It was sug-
gested that this heterogeneity was related to the variability in the cell-
cycle position of individual cells in growing cultures. Cell-cycle depen-
dent heat resistance has been reported in S. cerevisiae [140]. Further
work revealed that individual cells in S. cerevisiae subpopulations exhib-
ited a 1500-fold variation in the induction of the Hsp104 promoter by
mild heat shock [135]. The strength of the Hsp104 promoter induction
correlated with the cell-to-cell variation in resistance to a lethal heat
stress, establishing a phenotypic consequence for the heterogeneous
transcriptional response. The mechanistic basis for this heterogeneous
response is not genotypic (the phenotypes were not inherited); howev-
er, the role of the cell cycle or other parameters that could function as
the underlyingdriver of this heterogeneitywas not investigated. One in-
teresting observation that could be relevant is the short-period
(~3–6 min) shuttling to and from the nucleus exhibited by theane models.
Percentage changes compared to the pure membranes
BM BA PhA BM
7101
(121)
+4.3% +4.3% −18.4%
11,675
(116)
+2.9% +3% +4%
8049
(132)
+4.1% +4.6% −11.5%
17,110
(134)
−3.5% −3.5% +1.7%
n the molecular weight of the system (bilayer + solvent + ﬂuidizers). The error (within
imulations.
Fig. 4.Mass density proﬁles of SM/CHOL (135:137)membrane. The atom distribution of the pure membrane (A); upon the addition of BA (B), PhA (C), and BM (D). The dashed black line
representswatermolecules, the thin gray line is the overall density of SM. Cholesterol oxygens and carbon atoms are shown in red and blue, respectively. BA, PhA and BM are indicated in
green.
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sponse in S. cerevisiae during adaptation to mild stress [141].
Superimposed on this cyclical behavior is themarked heterogeneity be-
tween individual cells in the patterns and timing of Msn2p and Msn4p
shuttling. In continuous yeast cultures, nuclear localization of the
redox-sensitive transcription factor Yap1p is also known to oscillate
[142]. The respiratory oscillations in yeast – often termed ultradian
rhythms – could underlie phenotypic heterogeneity in a broad range
of resistance phenotypes. Linked to these oscillations, resistance to the
pro-oxidants hydrogen peroxide (H2O2) and menadione, as well as to
heat, cycled in phasewith each other; that is, resistances to these differ-
ent stressors reached maxima or minima at the same times during the
oscillation [143,144].
Resistance to an ‘uncoupler’ of mitochondria and to the toxic metal
cadmium also oscillated, but these were slightly out of phase with the
other stressors. Some preliminary evidence indicates that redox cycling
of antioxidants, such as glutathione, during respiratory oscillation could
underpin at least some of the above phenotypes [130]. Ultradian oscilla-
tions are typically believed to be linked to the cell division cycle. Direct
associations between cell-cycle position and pro-oxidant resistance
have been demonstrated; the G1 and G2 stages of the S. cerevisiae cell
cycle were identiﬁed as menadione-resistant and H2O2-resistant
phases, respectively [145].
Microvascular endothelial cells were shown to respond heteroge-
neously to shear stress. Data suggested that shear stress stimulates
cells to release ATP, causing the increase in intracellular calcium concen-
tration via purinergic receptors in cells that are heterogeneously sensi-
tive to ATP. By this means, ATP acts as an autocrine and paracrine
hormone, serving to integrate the heterogeneity of individual cell re-
sponses and coordinate vascular functions [146].
6.3. Cell to cell variation of membrane heterogeneity
In recent years, our understanding of the plasma membrane has
changed considerably as our knowledge of lipid microdomains has ex-
panded. These include structures known as lipid rafts and caveolae,
which are readily identiﬁed by their unique lipid constituents. Choles-
terol, sphingolipids and speciﬁc phospholipids with more saturated
fatty acyl chain moieties are typically highly enriched in these lipid mi-
crodomains. Since lipid microdomains have been widely shown to play
important roles in the compartmentalization, modulation and integra-
tion of cell signaling, we suggest that these microdomains may addi-
tionally have an inﬂuential role in stress sensing and signaling. Since
the raft structure is also dependent on the thermally controlled lipid-
phase behavior, evenmild changes in temperature could result in a fun-
damentally altered solubility and consequently redistribution of these
proteins in the rafts.More severe heatmay result in complete raft disso-
lution and disruption of the signaling activities [147].
The available literature data about cell population heterogeneity of
theheterogeneousmembrane structure is very limited. A higher hetero-
geneity of plasma membrane in multidrug-resistant LR73 carcinoma
cells was found in comparison with non-resistant cells [148]. A reduced
degree of heterogeneity was found upon treatmentwith themembrane
ﬂuidizing agent BA. A relation between the distribution of the diffusion-
time values and the modiﬁcation of membrane lateral heterogeneities
was proposed [148].
Our pilot studies on the heat shock response of B16 melanoma cells
showed a signiﬁcant variation of both membrane domain organization
and the expression level of Hsp70 promoter driven YFP (Peksel et al.,
unpublished).
6.4. “Zooming in” on membrane hyperstructures engaged in the generation
of stress signal
During or after the imposition of stress on cells we can zoom in on
individual cells or individual ﬂuorescently tagged molecules, using anultrasensitive, high-speed camera attached to a ﬂuorescence micro-
scope in TIRF mode to observe what happens in the membranes as
each cell reacts to the particular treatment. A change may occur in the
topology of a particular membrane domain, a candidate from which
an initial heat shock signal could originate, or a membrane receptor
may be activated, allowing the monitoring in real time as a receptor
complex responds and activates signaling pathways [99]. An intracellu-
lar signaling molecule tagged with a ﬂuorescent protein could light up
or could form a FRET pair as it interacts with another component of
the signaling pathway, perhaps relaying instructions to the nucleus to
activate or deactivate a particular stress defensive gene. The particularly
valuable aspect of this methodology is not the astounding visual images
it produces, but rather the abundant and diverse data that can be ex-
tracted from those images—data that afford a better understanding of
what is happening in the cell in response to stress. Image analysis of
this nature requires efﬁcient imaging algorithms, such as the open
source Cell Proﬁler (www.cellproﬁler.org), which provides a selection
of tools for automatic analysis of the cell morphology, and the localiza-
tion and intensity distribution of ﬂuorescent markers [149]. The avail-
ability of high content imaging tools allows us to link gene expression
to biochemical signaling pathways in individual cells and, ultimately,
to cell behavior. During or after the imposition of stresses on cells we
can zoom in on individual cells using ultrasensitive, high-content,
time-lapse ﬂuorescent microscopy with a very high spatial and tempo-
ral resolution to observe what happens as each cell reacts to the given
treatment. We developed robust tools for automatic image analysis to
follow the individuality of dynamic cellular events in a population of
cells during the development of the stress response. The results gained
with our cell proﬁling approach revealed speciﬁc, heat induced mem-
brane rearrangements (Peksel et al., unpublished). The ability of cells
to respond to stress correlated with the structure of the plasma mem-
brane prior the heat treatment. By changing this speciﬁc membrane
structure by chemical compounds the HSR could be altered and a selec-
tive remodeling of the HSR could be achieved [4].6.5. Lipidomics of the heat shock response
It is well established that stressful conditions activate numerous
membrane-related sensors at the top of the signaling pathways which
are interconnected by the parameters of the membrane chemical and
physical state. Phospholipids, sphingolipids and cholesterol are also in-
volved in stress-induced second messenger generation [4,150]. A pre-
cise identiﬁcation and quantitation of the cellular lipids is therefore a
prerequisite to map the interactions and dynamics of lipids during
stress response. The recent advances in mass spectrometric techniques
facilitated the development of lipidomics permitting reliable analysis of
multiple lipid species within short analysis time. The accurate quantiﬁ-
cation of individual lipid species provided new insights into membrane
structure, lipid metabolic pathways and metabolic ﬂux [151,152].
Lipidomics of the stress response in yeast uncovered the essential func-
tion of sphingolipids in heat protection coupled to their signaling role in
Hsp production [153–156]. The role of PLC and PLD in membrane-
related stress signaling events in plants was identiﬁed by these modern
technologies [157–160]. In mammalian systems, lipidomics revealed
pronounced and highly speciﬁc alterations in lipid composition,
pointing out the role of PLA2, PLC and sphingolipid metabolism during
stress-induced membrane perturbations [161,162]. The plethora of
new data requires new approaches for bioinformatic. Supervised and
unsupervised classiﬁcation methods, such as discriminant, cluster and
principal component analysis or other pattern recognition techniques
[163] together with the integration of lipidomics with transcriptomics,
proteomics and metabolomics [164] are introduced in order to under-
stand the biological role of lipid networks in stress management [150].
In summary, stress-lipidomics is developing rapidly as an emerging
ﬁeld and by its methodological innovations it is available to detect and
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duction of signaling metabolites.
7. Bridging the gap between plasma membranes and heat shock
genes: Heat Shock Factor 1 at the crossroad
7.1. Hsp expression is regulated by HSFs
Inducible expression of Hsps is controlled by members of the HSF
family. So far, four members are identiﬁed in vertebrates: HSF1 and
HSF2, which exist in all vertebrates, HSF3, which is present only in
avian species, and HSF4, which is only present in mammals [165]. Al-
though both HSF1 and HSF2 are involved in the heat-inducible regula-
tion of Hsps, most research has focused on HSF1.
Under optimal growth conditions, HSF1 shuttles as a latent mono-
mer between the cytoplasm and the nucleus in complex with Hsp90,
p23 and immunophilin. Upon elevated temperatures, this complex dis-
integrates; HSF1 accumulates in the nucleus, quickly undergoes several
post translational modiﬁcations, trimerizes as a homo- or heterotrimer
together with HSF2 [166] and binds to its recognition site (heat shock
element, HSE) in Hsp-promoter region and ultimately drives Hsp-
expression [167].
7.2. HSF1: a central hub of membrane-mediated stress signaling
Our understanding of how exactly the signal from heat percep-
tion at the plasma membrane is transduced toward HSF1 activation,
ultimately driving the expression of Hsps, is still incomplete and
fragmentary. However, over the last decades a complex interplay
of multiple pathways emerged in which derivatives of plasma mem-
brane phospholipids, sphingolipids and cholesterol all play impor-
tant roles (Fig. 5). Of these, PIP2 and ceramide play a central role in
the signaling transduction. For ease of interpretation, the signaling
cascades originating from the plasma membrane and activated
upon heat stress can be grouped according to the central second
messenger lipid moieties driving the cascade. In fact, PIP2 is the cen-
tral driver of both the inositol triphosphate/diacylglycerol signaling
and thephosphatidylinositol trisphosphate signaling cascades. Ceramide
on the other hand is at the middle of sphingosine- and cholesterol-
dependent signaling pathways. Next, sphingosylphosphorylcholine
(SPC)-mediated signaling constitutes an additional cascade which tar-
gets Hsp expression. Ultimately, most if not all, of these signaling cas-
cades affect the activity of HSF1, while a lot of potential crosstalk exists
between these signaling cascades. In the following paragraph, the differ-
ent signaling cascades will be outlined in more detail.
Recently, ligand-independent activation of the epidermal growth
factor receptor (EGFR) was shown upon lipid raft disruption [168]. It
was assumed that cholesterol depletion from the plasma membrane
by MBCD leads to the release of EGFR from the damaged raft into
small conﬁned areas of the membrane, where the receptor molecules
are likely to be spontaneously activated owing to a very high density
and/or separation from the inhibitory factors remaining in the sur-
rounding portions of the membrane. In addition, Simons and co-
workers most recently demonstrated, that the plasma membrane gan-
glioside GM3 alone, exhibits the potential to regulate the allosteric
structural transition from inactive to a signaling EGFR dimer, by
preventing the autophosphorylation of the intracellular kinase domain
in response to ligand binding [169]. Based on these ﬁndings, the “mem-
brane sensor” model hypothesizes that signaling from the transmem-
brane growth factor receptors to hsp genes can link plasma membrane
events to Hsp expression induced bymild heat and/or membrane ﬂuid-
izers [170]. As such,membrane rearrangement bymild heat or chemical
ﬂuidizers may activate growth factor receptor tyrosine kinases by caus-
ing their non-speciﬁc clustering [147].
Indeed, exposure to mild heat in a number of cell lines was shown to
activate EGFR [171]. Activation of GFR results in activation of PLC [172]and phosphatidylinositol-3-kinase (PI3K) [1], triggering the inositol tri-
phosphate/diacylglycerol and phosphatidylinositol triphosphate signal-
ing cascades, respectively. In fact, active PLC hydrolyzes PIP2 into
inositol triphosphate (IP3) and diacylglycerol (DAG) [173]. IP3 binds to
IP3 receptors (IP3R) – intracellular Ca2+ channels – causing the release
of Ca2+ from intracellular Ca2+ stores such as the endoplasmic reticulum
andGolgi apparatus. Of note, the heat-induced generation of IP3 and sub-
sequent Ca2+ inﬂux were shown to be decreased in PLC-deﬁcient
Arabidopsis mutants, while the expression levels of the small Hsps
Hsp18.2 and Hsp25.3 were decreased [174]. Subsequent release of Ca2+
into the cytoplasm has multiple effects including the activation of cal-
modulin kinase II (CaMKII), via the interaction with calcium–calmodulin
[175], and the activation of cytosolic phospholipase A2 (cPLA2) [172]. Ac-
tive CaMKII results in phosphorylation ofHSF1while cPLA2 drives the for-
mation of AA. In parallel, the initial generation of DAG by PLC from PIP2
leads to PKC activation and the additional formation of AA by the DAG
lipase–MAG lipase pathway [161]. DAG lipase is activated by phosphory-
lation by PKC and PKA while the molecular mechanisms by which MAG
lipase is activated are still elusive [176,177]. Activation of PKC contributes
to cPLA2 activation [178], which – either directly or indirectly via the ac-
tivation of the MAPK pathway – activates HSF1. AA formation also con-
tributes to the activation of HSF1 [162,179].
In parallel, GFR kinases result in the activation of PI3K leading to
the production of phosphatidylinositol-3,4,5-triphosphate (PIP3)
from PIP2 and subsequent parallel activation of AKT and Rac1
[180]. The serine/threonine kinase AKT links growth factor signaling
with Hsp response by both inhibiting the glycogen synthase kinase-3
(GSK3) and activating mTOR both of which result in subsequent
HSF1 activation [181,182]. In parallel, Rac1 plays a fundamental
role in a wide variety of cellular processes including Hsp response
[183]. Indeed, during moderate heat shock, activation of PI3K has
been observed [184] followed by activation of AKT [181] and Rac1
[183] ultimately resulting in enhanced Hsp expression levels.
Next to GFR-related signaling in HSR signaling, an essential contri-
bution of TRPV1 channels for efﬁcient induction of the HSR upon heat
was recently demonstrated [84]. In fact, activation of TRPV1 channels
results in an extra inﬂux of Ca2+ ions into the cytoplasm. Interestingly,
trafﬁcking of TRPV1 channels to the plasma membrane is mediated by
PKC and PI3K while the TRPV1 channels are sensitized by PLC [185]. In
addition, TRPV1 channels were shown to interact with Hsp70 suggest-
ing the contribution of Hsp70 to the trafﬁcking of TRPV1 to the mem-
brane and its stability in the plasma membrane [84].
Next to the phospholipid-dependent signaling cascades discussed so
far, also sphingolipid- and cholesterol-dependent signaling pathways
contribute to transduction of the heat shock signal. In fact, the produc-
tion of ceramide during heat stress, formed by the hydrolysis of
sphingomyelin by the action of acid sphingomyelinase (aSMase), has
been described and is of central importance to drive the sphingosine-
and cholesterol-dependent signaling cascades [161,186]. Although the
molecular mechanisms by which the activity of aSMase is regulated
are not completely understood, the involvement of oxidative stress
and PKC-mediated phosphorylation of aSMase have been suggested
[187–189]. Next, ceramide is deacylated by ceramidase (CDase) to
form sphingosinewhich can be subsequently phosphorylated by sphin-
gosine kinase 1 (SK1) resulting in the formation of spingosine-1-
phosphate (S1P) [190]. The activity of CDase is regulated by Ca2+
while the activity of SK1 is regulated by growth factor receptors via
PLD signaling [190,191]. Ultimately, although a direct effect on HSF1
has not been analyzed yet, S1P activates Hsp expression via p38 MAPK
and PI3K activation [192,193].
In parallel, ceramide can be glycosylated to form glucosylceramide
(GlcCer) by the enzymatic activity of glucosylceramide synthase
(GCS). Subsequently, the glucosemoiety of GlcCer is transferred to cho-
lesterol by the enzymatic activity of glucosyltransferase (SGT) [194].
This cascade ultimately drives the formation of cholesteryl glucoside
which results in HSF1 activation [195].
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dependent signaling cascades, increased ceramide levelsmight compete
with cholesterol for raft localization, ultimately forming ceramide-
enriched membrane microdomains [196]. It is assumed that by altering
the lipid composition of the raft, the signaling characteristics of these
rafts are modulated by qualitative and/or quantitative changes of raft-
residing proteins enabling the cell to better cope with a stressful envi-
ronment [147].
Finally, hydrolysis of sphingomyelin by the enzymatic activity of
sphingomyelin deacylase results in the formation of sphingosylphos-
phorylcholine (SPC) which, although a direct effect on HSF1 was not
studied, ultimately drives Hsp27 expression via p38 MAPK signaling
[197].
7.3. Plasma membrane modiﬁcations can modulate HSF1 activity in the
absence of stress
Some of our current knowledge evidencing the central role of the
plasma membrane in stress sensing comes in fact from several experi-
ments in which lipid derivatives were shown to activate HSF1 and/or
elicit a HSR in the absence of stress. Indeed, exogenous administration
of cholesteryl glucoside to human fetal lung ﬁbroblast (TIG3) cells was
shown to activate HSF1 in the absence of stress [198]. In addition, exog-
enous administration of reactive aldehydes such as 4-hydroxynonenal
(HNE) and crotonaldehyde (CRA), both plasma membrane lipid perox-
idation end products, was shown to activate HSF1. In fact, HNE is the
major α, β-unsaturated aldehyde derived from peroxidation of
omega-6 polyunsaturated fatty acids, while CRA is an α, β-
unsaturated aldehyde which is, next to being an important toxicHS
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Fig. 5. HSF1 is targeted by multiple membrane-originating stress-induced signaling cascades. Th
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Both in vitro as well as upon exogenous administration to RKO colon
carcinoma cells, HNE resulted in HSF1 activation [199,200]. At the mo-
lecular level, HNE was shown to modify Hsp70, Hsp90 and the HSF1
transcription repressor Daxx, thereby disrupting the inhibitory interac-
tion between these proteins and HSF1 [201,202], ultimately enabling
HSF1 to bind its DNA recognition site anddriveHsp expression. Also, ex-
ogenous addition of CRA to human umbilical vein endothelial (HUVEC)
cells was shown to cause nuclear accumulation of HSF1 leading to
Hsp70 upregulation while, at the molecular level, the involvement of
the c-Jun kinase pathway, the availability of Ca2+ ions, and the presence
of reactive oxygen species were demonstrated [203]. Next to exogenous
administration of lipid derivatives to cells, mechanical deformations of
the plasma membrane, caused by mechanical stress, were equally
shown to result in HSF1 activation. Indeed, in both synovial ﬁbroblast-
like cells (SFC) and in atherosclerotic lesions from an animal model of
arthritis, active HSF1 was observed [204,205]. Moreover, mechanical
stretching of smooth muscle cells resulted in HSF1 translocation from
the cytoplasm to the nucleus and hyperphosphorylation followed by in-
creased Hsp70 expression [204].
While being at the ﬁrst stage of stress sensing, the plasma mem-
brane might actually represent a tool allowing us to modulate HSF1 ac-
tivity ultimately inﬂuencing the outcome of HSR. Considering that a
deregulation of the HSR is central to several high prevalence disease
states such as cancer and neurodegenerative diseases, the ability to in-
ﬂuence the HSR by modulating HSF1 activity is indeed of high clinical
relevance. In the next paragraph, we will outline howmembrane ﬂuid-
ization and membrane intercalating hydroximic acid derivativesF1
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e signaling cascades originating from the plasma membrane and activated upon heat stress
is the central driver of both the inositol trisphosphate/diacylglycerol signaling and the phos-
olesterol-dependent signaling pathways. Sphingosylphosphorylcholine (SPC)-mediated sig-
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7.3.1. Plasma membrane ﬂuidization by benzyl alcohol activates HSF1
By intercalating between membrane lipids, BA causes a disordering
effect due to weakening of the van der Waals interactions between
the lipid acyl chains. As such, it was demonstrated in human
erythromyeloblastoid leukemia K562 cells that BA is able to induce sim-
ilar changes in membrane ﬂuidity comparable to that induced by mild
heat stress exposure in a dose-dependent manner [113]. Consequently,
BAwas able to induce a heat shock response at the normal growth tem-
peratures in the absence of general proteotoxicity, while causing a
downshift in the temperature threshold of the heat shock response. In-
terestingly, BA was able to provoke a distinct HSR at growth tempera-
ture comparable to heat stress [99]. At the cellular level, a Ca2+ inﬂux
similar to that seen during heat shockwas observed in parallel withmi-
tochondrial membrane depolarization [113]. Subsequently, it was
shown in mouse embryonic ﬁbroblast cells (MEF) that Hsp-induction
by BA was dependent on HSF1 activation [99]. Interestingly, in mouse
melanoma B16 cells, it was found that, while a general increase in plas-
ma membrane ﬂuidity was observed, BA speciﬁcally caused structural
changes in the microdomain (raft) structure [99]. Based on these ﬁnd-
ings it was suggested that rather than plasma membrane ﬂuidization
per se, a speciﬁc reorganization of cholesterol-rich raft structures
might be responsible for the generation and transmission of stress sig-
nals ultimately resulting in Hsp gene activation.
7.3.2. Plasmamembrane lipid raft intercalating compoundsmodulate HSF1
Hydroximic acid derivatives, including BGP-15 and BM, are well
established Hsp co-inducers [8]. For example, the multi target drug
BGP-15 has proven clinical effects in animal models of muscular dystro-
phy, atrial ﬁbrillation, and type 2 diabetes [8]. Although the precisemo-
lecular mode of action of BGP-15 is not yet completely clear, it has
recently been shown that BGP-15 is able to increase the stability of
cholesterol/sphingomyelin complexes in in vitro monolayer experi-
ments [127]. Furthermore, upon labeling of lipid rafts with mGFP-GPI,
it was shown in B16 cells that BGP-15was capable to preserve the integ-
rity of these rafts when challenged by thermal stress [127]. Interesting-
ly, in parallel to the previous observation with BA [99], this study
revealed that BGP-15 also affected the size and the distribution of lipid
rafts in heat shock response-deﬁcient B16 cells while restoring the ca-
pacity of these cells to upregulate Hsps upon heat exposure [127].
Based on these observations, it was suggested that raft reorganization
is coupled with the triggering of raft-associated stress sensing and sig-
naling pathways. Considering the previous observations that BM – a
BGP-15 predecessor – could prolong the activation of HSF1 [206] com-
bined with a report suggesting that acetylation of HSF1 attenuated the
HSR [207], the effect of BGP-15 on HSF1 acetylation was analyzed. As
such, it was demonstrated that pre-treatment of human embryonic kid-
ney (HEK293) cells with BGP-15 resulted in reduced HSF1-acetylation
suggesting prolonged activation of HSF1 [127]. Taken together, by inter-
calating into the plasmamembrane and causing lipid raft remodeling, it
is suggested that BGP-15 might be able to co-induce the HSR by reduc-
ing the total amount of HSF1 acetylation.
8. Genetic modiﬁcation of a pathogen's membrane physical state
alters the heat shock response and causes loss of virulence of
Salmonella Typhimurium LT2 and Histoplasma capsulatum
In microorganisms, plants and other poikilotherms (organisms
whose body temperature varies with the environmental temperature)
gradual changes in growth temperature modify the cell's membrane
physical state (MPS) [208] resetting the threshold temperature at
which Hsps are synthesized under stress conditions [5,209]. It has
been shown that under physiological temperatures, MPS, regulated by
the environmental temperature, is controlled by lipid unsaturation,protein–lipid ratio, composition of lipid molecular species, etc., that de-
termine the temperature at which heat shock genes are transcribed
[5,210]. One of the factors in regulating the MPS is represented by
fatty acid desaturases (Δ5, Δ9, Δ12, etc.), enzymes which introduce a
double bond in a speciﬁc position in long-chain fatty acids [211]. Fur-
ther, the unsaturation of fatty acids in glycerolipids is essential for the
proper functioning of biological membranes.
We have studied the role of the MPS during the Mϕ infection in the
important human and animal pathogens S. enterica serovar Typhimurium
and in the human fungal pathogen H. capsulatumwhose mechanisms of
virulence are well characterized. We have shown that in S. typhimurium
the alteration of the MPS induced by expression of heterologous
SynechocystisΔ12-desaturase or its trans-membrane spanning regions al-
ters the pattern of Hsp accumulation,which is of signiﬁcant biological im-
portance for the organism's pathogenicity.
8.1. Effects of expression of heterologous Synechocystis Δ12-desaturase on
membrane physical state of S. typhimurium
We had demonstrated that the primary sensor of temperature vari-
ations and, of other forms of stresses is localized in the plasma mem-
brane [210,212]. More recently, we and others have shown that a heat
shock or an exposure to other stressors determines a physical reorgani-
zation of lipid and protein membrane components [4,147,150,213] that
is followed by a speciﬁc gene response designed to, among other things,
compensate variations in theMPS [3,214]. Fluidity andmicrodomain or-
ganization of membrane are strictly involved in the perception and
transduction of stressors (e.g. heat) into secondary signals that induce
transcription of speciﬁc heat shock genes [215,216]. Under stress condi-
tions, a reversible association of speciﬁc Hsps with membranes may re-
establish their ﬂuidity and bilayer stability and, thereby, restore mem-
brane functionality.
We have studied the role of the membrane during Mϕ infection in
S. typhimurium and showed that an abrupt change ofMPS alters the pat-
tern of Hsp accumulation, which eventually has profound biological sig-
niﬁcance for the organism's pathogenicity [217]. S. typhimurium genome
does not contain anyΔ9-fatty acid desaturase (S. enterica subsp. enterica
serovar Typhimurium str. LT2: http://www.ncbi.nlm.nih.gov/genome/
152?project_id=57799), hence, it does not produce oleic acid (18:1)
which is the natural substrate for Δ12-fatty acid desaturase. Expression
of Synechocystis Δ12-desaturase in S. typhimurium caused a signiﬁcant
imbalance in MPS due to the higher protein/lipid ratio and membrane
leakage. The protein which is a membrane-bound enzyme [218] has
no enzymatic activity in Salmonella, thus, its perturbing effect on the
MPS is due to its insertion in the membrane rather than to a change in
phospholipid composition.
The fatty acid chain length was similar in control strain and trans-
formed S. typhimurium, though lipid unsaturation decreased of ca. 20%
in S. typhimurium expressing either the entireΔ12-desaturase coding se-
quence or the two trans-membrane regions of the protein. The insertion
of the peptides or the full protein caused a change in MPS while cells
compensated for the increased ﬂuidity by reducing the unsaturation of
their membrane lipids. The most signiﬁcant change was a decrease of
16:1 and the increase of 18:0 fatty acids.
Further, perturbation of membrane functionality and destabilization
caused by the insertion of Δ12-desaturase were determined by measur-
ing the uptake of 1-N-phenylnaphthylamine (NPN) ﬂuorophore, which
correlates with membrane permeability. The perturbation was signiﬁ-
cant in the normal temperature range of 25 to 40 °Cwhile it was not de-
tected at higher temperatures. Such results were conﬁrmed by
differential scanning calorimetry on isolated membrane. Furthermore,
insertion of Δ12-desaturase in membrane lowered the transition tem-
perature of certain lipid domains in the outer membranes of Salmonella.
Therefore, S. typhimurium expressing Δ12-desaturase gene had greater
permeability in the outer membrane, under stress and non-stressing
conditions. Recently, Yamamoto and Ando have shown that endothelial
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phase order and postulated that these changes could be linked to
shear stress sensing and to responsemechanisms [219]. Possibly, the al-
teredmembrane organization induced a compensatorymechanism that
may comprise alteration of the ratio of gel-ﬂuid lipid domains [220].
Furthermore, when S. typhimurium was incubated for 30 min with
different concentrations (between 5 and 80 mM) of BA and then plated
on LB agar, no toxic effect was detected up to 50 mMBA on cell viability
[113,212]. We and others had shown previously that BA and heptanol,
bothmembrane ﬂuidizers, do not cause protein denaturation at concen-
trations that induced the HSR [221] at non-inducing heat shock temper-
atures, implying that the transcription of heat shock genes was due to
their interaction with the membrane [4].
Insertion of the whole Δ12-desaturase or its trans-membrane pep-
tides perturbed signiﬁcantly the MPS of Salmonella membrane and
reset the optimal temperature of expression of heat shock genes. Fig. 6
shows that, while in normal cells a heat shock between 38 and 47 °C
caused a progressive increase of the small heat shock proteins dnaK
and ibpB transcription, transformed cells had a reverse pattern which
was reduced at high temperatures. In addition, ibpB was overexpressed
in transformed Salmonella at physiological temperature, suggesting that
insertion of Δ12-desaturase protein in the membrane fraction induced a
complex compensatory mechanism that included alteration of the
phase transition temperature of certain lipid domains [5,147]. These re-
sults were further corroborated by MALDI [222] and MS-Fit database
analyses [223] that showed association of IbpA and IbpB to the outer
membrane fraction. Thus, the behavior of Salmonella in response to
the expression of the entire Δ12-desaturase gene is, at least in part,
due to the insertion of the protein in its membrane supporting our
model that comprises a cross talk between changes in MPS and tran-
scriptional regulation of genes involved in lipid metabolism and in
HSR [3,224].
However, the effect of perturbation by Δ12-desaturase (or its trans-
membrane domains) on the MPS and the HSR can be obtained also by
using other membrane proteins unrelated to fatty acid metabolism or
desaturation, aswehave shownbyexpressingα-crystallin in eukaryotic
cells. Further, we have shown recently by RNAseq analysis that the ex-
pression of one of the two trans-membrane regions of Δ12-desaturase
gene alters the pattern of expression not only of heat shock genes but
also of genes that are involved in the adaptation to conditions present
in Mϕ and in virulence (Porta et al., unpublished data). These changes
are likely due to the insertion of the trans-membrane spanning regions
of two-component histidine kinase sensors (e.g. PhoP/PhoQ [225];
PmrA–PmrB; [226]).Fig. 6. Pattern of expression of dnaK in wild type (Salmonella) and genetically modiﬁed
S. Typhimurium (Salmonella Δ12) grown at 37 °C. dnaK was poorly expressed at 37 °C
in wild type cells but was highly transcribed in the genetically modiﬁed strain. When
cells were heat shocked between 39 and 47 °C, dnaK expression increased up to 47 °C
while it progressively decreased up to 45 °C and was poorly transcribed at 47 °C.Thus, the imbalance in the membrane lipid/protein ratio, due to
overexpression either of Δ12-desaturase or individually expressed
trans-membrane regions of this protein, caused major changes in MPS
and a signiﬁcant reduction of the HSR, implying that in S. typhimurium
the perception of temperature is strictly controlled by membrane
order andby a speciﬁcmembrane lipid/protein ratio. Further, the capac-
ity to control the level of Hsps allows the possibility to produce patho-
gens with a reduced capacity to adapt to the host environment at the
onset of infection [227].
8.2. Attenuation of virulence, membrane ﬂuid state and heat shock response
of H. capsulatum
So far, a methodology to obtain live attenuated strains has not been
obtained for fungal pathogens. Live attenuated strains of human proto-
zoa such as Toxoplasma, Leishmania or of other parasites to develop vac-
cines have been produced. However, so far none of these candidate
vaccines has been considered suitable for clinical use [228,229]. Recent-
ly, an alternate strategy to vaccines based on puriﬁed antigens has been
used exploiting the notion that low-density infections induce antibody-
independent immunity to different strains of Plasmodium [230]. These
authors treated parasitized red blood cells from the rodent parasite
Plasmodium chabaudi with seco-cyclopropyl pyrrolo indole analogs,
drugs that irreversibly alkylate parasite DNA, blocking its replication.
Immunity was mediated by CD4+ T cells and was dependent on the in-
tegrity of red blood cell membrane. These experiments demonstrated
that vaccination with chemically attenuated parasites induces protec-
tive immunity.
However, a method to obtain live attenuated fungal pathogens has
not been found. The production of genetically modiﬁed pathogens that
lack virulence or essential genes is considered the main alternative for
developing an effective protective vaccine. Present genetic procedures
are based on the use of mutations or deletions of speciﬁc (virulence)
genes that may cause attenuation and are species-speciﬁc. Thus, a
given method of attenuation may be effective in a speciﬁc organism
but not in other pathogens.
We had shown previously that modulation of theMPS of the human
fungal pathogen H. capsulatum by treatment with BA [212] or by alter-
ation of the saturated/unsaturated (SFA/UFA) ratio caused a reduced
HSR. These results encouraged us to investigate the effect of reduced
levels of Hsps on the virulence of this pathogen at the onset of infection
in Mϕ and in a mouse model of infection by overexpressing a homolo-
gousΔ9-desaturase gene in the highly virulent G217B strain of this fun-
gal pathogen.
8.3. H. capsulatum Hsp70 gene expression, MΦ and mouse infection
We constructed a G217B mutant strain carrying an extra copy of its
own Δ9-desaturase gene under the transcriptional control of the up-
regulated DownsΔ9-desaturase promoter [231]. The parental strain ex-
presses Hsp70 between 34 and 42 °Cwith a maximum at 37 °C, the ge-
netically modiﬁed strain did not express this gene at 37 °C, but at the
higher temperature of 42 °C. This result was similar to that of wild
type strain treated with oleic acid (an UFA) or BA in which Hsp82 tran-
scription was hampered. The mutant strain, as well as the strain treated
with BA or with an UFA, had a more ﬂuid membrane. H. capsulatum
G217B and the genetically altered strain were added to a Mϕmonolayer
at 37 °C to test their capacity to survive within these cells that constitute
the natural environment that allow growth of ‘yeast’ phase cells (the
pathogenic form of the dimorphic H. capsulatum) in a susceptible mam-
malian host. Contrary to control cells, the altered strain after internaliza-
tion did not grow inside Mϕ and no fungal cells were recovered after 8 h
of infection.
Increasing concentrations of yeast phase cells of the virulent G217B
or of the genetically modiﬁed H. capsulatum strain (106, 107, and
5 × 107) were injected intravenously into CD-1 mice. All mice injected
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107 survived up to 40 days. Mice infected with the higher dose of yeast
cells of the virulent G217B strain (5 × 107) died within 6 days, while 7
out of 10 mice infected with the same inoculum of the modiﬁed strain
survived up to 45 days after infection (Fig. 7). Forty days after the initial
infection with the modiﬁed strain, the surviving mice were re-infected
with a lethal dose (5 × 107 yeast cells) of the virulent G217B strain.
Sixty per cent of the initial group of the pre-treated mice (60 days
from the initial infection) 20 days after infection still survived, while
allmice injected, as control in parallelwith the virulent strain diedwith-
in 6 days after the inoculum (Fig. 7).
In conclusion,Hsps have been implicated in the stimulation and gen-
eration of both innate and adaptive immunity in a wide variety of mi-
croorganisms, eliciting humoral responses during natural infection
with various pathogens. Anti-Hsp70 antibodies have been detected in
patients with chronic parasitosis and Hsp70 of Plasmodium falciparum,
Schistosomamansoni, andH. capsulatumhave also been shown to induce
a cell-mediated immune response [232]. A putative role for Hsp90 in
immunity has also been proposed [233]. However, vaccination with re-
combinant proteins does not protectmice, thus, though Hsps have anti-
genic properties, they do not mediate protection. Our approach is based
on the alteration of the HSR to reduce rather than stimulate the synthe-
sis of Hsps, to generate a strain defective in the process of stress adapta-
tion. Intracellular pathogens at the onset of infection induce the
transcriptional activation of stress genes along with other species-
speciﬁc genes, broadly deﬁned as virulence genes. The latter class of
gene products is involved in the mechanisms of invasion/adaptation,
and is responsible for the capacity of the pathogen to invade, replicate,
and induce disease in the host [234]. Thus, expression of stress genes
and those involved in virulence is temporarily associated and transcrip-
tionally coordinated [235].
We have shown that it is possible to obtain with a single genetic
modiﬁcation a new procedure to produce an attenuated strain from
the highly virulent fungus H. capsulatum by repressing the HSR. We
have modiﬁed H. capsulatum with a gene involved in the regulation of
the MPS, causing impairment of the pathogen's stress response that
causes a parallel failure of the pathogen to survive within MΦ (as
shown in Salmonella in a previous section) and to cause disease in a
mousemodel of infection. Further, the genetically-modiﬁed and attenu-
ated H. capsulatum strain induced protection in mice after subsequent
challenge with a highly virulent strain.
More recently, we have used the Salmonella strain expressing a
trans-membrane region of Synechocystis Δ12-desaturase gene and test-
ed its efﬁcacy in a murinemodel of infection (Porta et al., unpublished).
We obtained similar positive results. Further, we have monitored the
immune response during infection and analyzed by RNAseq the proﬁleFig. 7.Mouse infection with H. capsulatum. Mice infected with 5 × 107 G217B yeast cells
died within 6 days, while 70% of mice infected with the same inoculum of genetically
modiﬁed strain (G217B Δ9) survived up to 40 days after infection. Then surviving mice
were challenged with a lethal dose of the virulent strain G217B (5 × 107). After 20 days
(60 days from the initial infection with attenuated genetically modiﬁed strain) 60% of
mice still survived.ofmRNA transcription of themodiﬁed Salmonella strain.We could show
that the strain induced a full immune protection and an altered HSR as
well as a strong impairment of transcription of virulent genes.
Since this procedure is effective both in prokaryotes as well as eu-
karyotic pathogens, it may be possible that attenuation of virulence ob-
tained by modiﬁcation of MPS and HSR might be applied to other very
important intracellular pathogens, such as mycobacteria, staphylococci,
streptococci, Pseudomonas and parasites.
9. From bench to bedside: therapeutic applications of heat shock
protein-modifying agents
Since Ritossa's ﬁrst observation ﬁfty years ago that heat shock in-
duced swelling on a Drosophila chromosomewhich led to the discovery
of heat shock proteins, approximately 50,000 publications have been
published on these stress-protecting proteins [236].While basic science
research offers a major understanding of how the proteins aid survival
and robust living, therapeutic application of Hsp induction to human
disease states remains a promise and not a reality. We believe that we
are at the dawn of a renaissance in drug discovery. A host of previously
untreatable or inadequately treated diseases are likely to be prevented
or at least modiﬁed beneﬁcially to lessen the impact on health.
As cyto-protective agents, Hsps enable cells and thus organ systems
to resist aswell as recover from stress. Hsps preserve cellular organelles,
delay or prevent apoptosis, reduce oxidative and free radical damage,
limit inﬂammatory response, aid in immune tolerance or augment im-
mune activation, remove irreversible damaged cellular proteins, and
enhance the gut-body barrier.
Studies in the late 1980s revealed that a brief febrile range heat
shock that raised cellular Hsps could condition an animal to better toler-
ate an insult. In particular, Barbe, Tytell and coworkers observed that
15 minof hyperthermia at 41 °C induced amarked decrease in photore-
ceptor damage after exposure to bright light as compared to normother-
mic animals [237]. New studies demonstrate that hyperthermia
preconditioning can improve survival from sepsis [238], stroke [239],
myocardial infarction [240], hepatic ischemia [241], surgical wound
healing [242], surgical tendon repair [243], and organ transplant surviv-
al [244]. Hyperthemia is also therapeutic in osteoarthritis [245], type 2
diabetes (glycemic control, neuropathy and nephropathy) [246,247],
and in some cancer therapies [248]. While whole body hyperthermia
or localized heat application holds a real therapeutic option in certain
diseases, its practical application is limited by time constraints and
availability. However, the heat studies support the notion thatmajor pa-
thologies are amenable to heat therapy and support the concept that
agents mimicking the biologic effect of heat might also be effective
therapies.
Membrane remodeling agents may act like heat by alarming the cell
that its membrane bilayer is “melting” and thereby initiate the heat
shock stress response. Indeed, we earlier reported that the thermal
shift of membrane ﬂuidity induced by heat is duplicated by membrane
ﬂuidizers such as BA and heptanol [150]. Diverse Hsp inducers and co-
inducing agents have been studied in animal disease models. While
not all of these agents alter membrane ﬂuidity, their efﬁcacy in treating
pathology via Hsp induction predicts the potential for unrelated Hsp in-
ducers to be similarly capable of therapeutic beneﬁt.
An array of diseases is associated with inadequate or decreased Hsp
response. Deﬁcient Hsp conditions include aging itself [249], certain
acute catastrophic diseases (sepsis [250], acute respiratory distress syn-
drome [251], extensive body burns [252], pancreatitis [253]), chronic
illnesses (diabetes (both types 1 and 2) [254,255], colitis [256], psoriasis
[257], neuro-degenerative disease [258,259], renal failure [260], ciga-
rette smoking [261], and chronic obstructive lung disease [262]).
Additionally, genetic deﬁciencies of Hsps, chaperonopathies, have
been described: Bardet–Biedl syndrome (BBS), neuropathies associated
withmutations in small Hsps, Williams syndrome (WS), dilated cardio-
myopathies (DCs), and ataxia of Charlevoix–Saguenay (ARSACS) [263].
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cessive accumulation ormisfolding of proteins that can lead tomalfunc-
tion and cellular demise. Many of these diseases are associated with
aging and neurodegeneration, including Alzheimer's, Parkinson's,
amyotrophic lateral sclerosis (ALS), and certain muscular dystrophies.
Atrophic states like macular degeneration and retinitis pigmentosa ap-
pear to respond to anti-trophic Hsp agents [264].
Acute injury events beneﬁt from augmented stress response: post
stroke, myocardial infarction, trauma, auto accidents or surgery, renal
dialysis, retinal detachment, sunburn and heat stroke. As organs lose
function, due to disease or life events, a heightened stress response
could beneﬁcially limit further organ damage or even restore it (heart,
kidney, liver, skeletal muscle, retina). Finally, Hsp-inducing agents aid
tolerance and survival of toxins (acetaminophen (APAP) over dose
[265], chemotherapy [266], excessive alcohol consumption [267]).
Autoimmune diseases such as type 1 diabetes and adjuvant-induced
arthritis can bemodiﬁed by Hsp exposure or induction. Hsps increase T
lymphocyte regulatory cells that ultimately reduce intolerance to self-
antigens — like to the pancreas beta cell or to the joint synovia
[268,269].
Cancer therapies can beneﬁt from pharmacologic manipulation of
Hsps in several ways. First, toxicity due to oncologic therapies can be
limited byHsp induction. Second, some of the agents like thehydroximic
acid derivative BGP-15 and alpha lipoic acid (LPA) reduce tumor volume
[270,271]. Finally, Hsp expression in cancer is often elevated in tumors
and is associatedwith enhancedmetastatic potential. Agents that reduce
cancer Hsp levels can effectively be used as oncolytics. Provocatively, in-
duction of unique viral infection can reduce tumor Hsp expression and
result in oncolysis while maintaining organism well being [272]. With
cardiovascular disease as the major contributor to mortality in Western
Society, it is important to address how endothelial function can bemain-
tained as endothelial dysfunction and loss of nitric oxide production is
viewed as the hallmark of vascular disease. Relevantly, heat therapies
as well as the TRPV activator capsaicin increase nitric oxide production
by the endothelium and can, indeed, reduce ischemic vascular events
[273,274]. Recent studies indicate that the heat sensor TRPV activation
releases intracellular calcium that is then key in endothelial nitric
oxide release. TRPV activation blocks attenuate the increased vascular
tone of norepinephrine on the thoracic aorta [275].
To date, the major Hsp inducers are the hydroximic acids,
geranylgeranylacetone, LPA, xenohormones, heme oxygenase
inducers and chemical chaperones. Geranylgeranylacetone, a
membrane-ﬂuidizing compound, was shown to restore the mem-
brane ﬂuidity that was compromised by nonsteroidal anti-
inﬂammatory drugs [276]. Table 3 demonstrates the diverse diseases
with therapeutic effect in animal models of disease or in actual dis-
eases with these agents. Often, these agents are effective with oral
ingestion and have limited toxicity or side effects.Table 3
Therapeutic Hsp inducers and disease states responsive to therapy.
Hsp inducer Disease State
Hydroximic acids Insulin resistance and diabetes [281,282] and its compl
reperfusion [287], APAP toxicity [265], chemotherapeu
[271], sun burn [291], vascular hypertension damage [2
pancreatitis [296], ethanol intoxication [297], muscular
Geranylgeranylacetone Atrial ﬁbrillation [299], bleomycin-induced pulmonary
[303], post-surgical survival [304], autoimmune uveore
APAP toxicity [309], acoustic injury [310], endotoxin sh
infection [314], heat stroke [315], and insulin resistanc
Alpha-lipoic acid Insulin resistance [317], diabetic retinopathy [318], neu
[322], fatty liver [323], renal vascular hypertension [324
[327], serum lipids [328], drug toxicity [329]
Hemeoxygenase inducers Insulin resistance [330], type 1 diabetes [331], diabetic
dysfunction [334,335], fatty liver [334], bone mass [336
Chemical chaperones Insulin resistance [339], Fabry disease [340], Gaucher dis
[347], protein folding diseases [348], macular degeneraNutritional substances from plants have long been used by all cul-
tures to treat disease. Animals can take advantage of stress-generated
bioactive products of plants, termed xenohormesis. The xenohormones
can, when ingested, improve health and ﬁtness by activating the
animal's cellular stress response. In particular, the plant substances
that raise Hsps and are associated with extension of life span are resver-
atrol, curcumin, and salicylate. Plant compounds that raise Hsps but cur-
rently have no proven longevity effects are rosmarinic acid, ferulic acid,
jasmonic acid, and carvacrol [277]. A combination of Hsp-inducing herbs
has been formulated in Scandinavia, Adapt 232 (iherb.com), which has
been studied in multiple large, placebo-controlled human studies. As
such, it is known that Adapt 232 is associated with improvement in
well-being, exercise endurance, and memory in patients with chronic
fatigue syndrome [278]. Similarly, an ethanol extract from prickly pear
cactus (Prepair, TEX-OE) raises Hsps and improves exercise endurance,
reduces alcohol hangover symptoms, aids in sperm preservation of
ﬁsh for breeding, and improves survival in animal transport [279,280].
Taken together, the impact of disease on people's lives is incalcula-
ble. Imagine a family devastated by a disease like autosomal retinitis
pigmentosa. Given that their blindness does not appear until adoles-
cence or later—an intervention like anHsp inducer couldmodify the dis-
ease process and prevent vision loss and secondary sequela like
depression and suicide. To be able to treat diverse diseases amenable
to Hsp modifying agents could lessen human tragedy and ultimately
lead to higher quality, more enjoyable, longer lasting lives.10. Concluding remarks
Over the last decade, multiple studies have suggested that cells have
the ability to sense and respond to stress signals through the activation
of membrane-associated signal transduction pathways. As the integrity
of membrane nanoplatforms strongly depends on the thermally-
controlled lipid-phase behavior, it is assumed that even mild changes
in temperature might result in a redistribution and modiﬁed activity
of potential stress-sensing/signaling proteins within these subdomains.
Here, based on singlemolecule tracking, we provide new evidence indi-
cating that even a fever-type temperature stress results in distinct struc-
tural changes to the plasma membrane. Interestingly, the fever-type
temperature-induced membrane changes also alter the interacting be-
havior of membrane-residing proteins in a cholesterol-dependentman-
ner, suggesting modulations of raft residing proteins, which potentially
alter the signaling behavior of the nanoplatforms. In fact, the thermally
gated TRP channels represent one of the potential membrane-residing
heat sensors whose activity is lipid-modulated in several ways, includ-
ing directly affecting the channel properties, acting as allostericmodula-
tors altering the sensitivity to other agonists, or by indirect effects in
which changes in the mechanical properties of the membrane lead toications (neuropathy [283,284], retinopathy [285], wound healing [286]) ischemia
tic neuropathy [288], intracranial hemorrhage [289], atrial ﬁbrillation [290], hepatoma
92], myocardial infarction [293], amyotrophic lateral sclerosis [294], brain hypoxia [295],
dystrophy [298]
ﬁbrosis [300], drug induced gastritis [301], cardiomyopathy [302], myocardial infarction
tinitis [305], intra-cerebral hemorrhage [306], cerebral infarction [307], colitis [308],
ock [311], glaucoma-induced retinal damage [312], retinal detachment [313], inﬂuenza
e [316].
ropathy [319], cardiomyopathy [320], periodontitis [321], postmenopausal bone loss
], pesticide poisoning [325], cancer [270], cerebral ischemia [326], post-surgical ﬁbrosis
nephropathy [332], ischemia reperfusion in diabetic heart [333], diabetic cardiac
], drug renal toxicity [337], renal vascular hypertension [338]
ease [341,342], cardiacﬁbrosis [343], pancreatitis [344], Battendisease [345,346], cancer
tion [349]
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roids, in altering membrane ﬂuidity and stimulating membrane micro-
domain restructuring could inﬂuence stress response on the base of
the membrane thermosensor concept. This establishes a nice link be-
tween the organismal stress response and the cellular stress response
originating at the level ofmembrane sensing. Computational techniques
such as molecular dynamics simulations allow us to gain insight in the
lipid environment without the use of bilayer-perturbing probes.
Exploiting MD, here we report that established compounds having a
pronounced effect on the expression of Hsps (BA, PhA, and BM) are ca-
pable of altering lipidmembranes, in amanner similar to thermal stress.
Once the plasma membrane-originating heat-induced signal is gen-
erated, it is transduced toward HSF1, ultimately driving the expression
of Hsps via a complex interplay ofmultiple pathways. Prominent, mem-
brane associated signaling cascades playing key role in the regulation of
HSF1 activity and thereby the expression of Hsps are summarized.
Considering that multiple diseases are associated with inade-
quate or decreased Hsp response, plasma membrane integrity mod-
ulating tools that are able to inﬂuence the HSR were documented.
Hsp-modulating strategies centering on (plasma) membrane modu-
lations are potentially of high therapeutic value. The mode of action
of membrane-intercalating Hsp-modulators fully supports the
“membrane thermosensor” concept which has great potential for
use in ‘membrane-lipid therapy’. Beyond classical pharmacological
interventions, here we also present evidence that by genetically
modifying the membrane physical state of Salmonella Typhimurium
LT2 and H. capsulatum, the HSR can be altered concomitantly
resulting in a loss of virulence of these pathogens.
By the application of high-content ultrasensitive methods, including
image based cell proﬁling and/or lipidomics, we can identify speciﬁc
changes inmembrane domain structure leading to selective reﬁnement
of the expression of Hsps. This approach can open novel avenues in the
therapeutic interventions of most various diseases.
Acknowledgements
This work was supported by grants from the Hungarian Basic Re-
search Fund (OTKA NK100857, PD109539, MB08B 81822), the Hungari-
an National Development Agency (TÁMOP-4.2.2.A-11/1/KONV-2012-
0073 and TÁMOP-4.2.2.A-11/1/KONV-2012-0052), the Hungary-Serbia
IPA Cross-Border Cooperation Programme (HUSRB/1002/214/126), the
New Szechenyi Plan, GOP, Hungary (GOP-1.1.1-11-2011-026, GOP-
1.1.1-11-2012-0147, GOP-1.1.1-11-2012-0452), the FARB-MIUR/2012,
Italy, the SAF2010-14990 and PROMETEO2010-046, Spain, the Austrian
Science Fund/FWF (I301-B12), and the Natural Sciences and Engineering
Research Council of Canada (NSERC) Discovery Grant and Postgraduate
Scholarship to LD.
References
[1] D. Kultz, Molecular and evolutionary basis of the cellular stress response, Annu.
Rev. Physiol. 67 (2005) 225.
[2] T. Gidalevitz, V. Prahlad, R.I. Morimoto, The stress of protein misfolding: from sin-
gle cells to multicellular organisms, Cold Spring Harb. Perspect. Biol. 3 (2011).
[3] I.Horvath,G.Multhoff, A. Sonnleitner, L. Vigh,Membrane-associated stress proteins:
more than simply chaperones, Biochim. Biophys. Acta 1778 (2008) 1653.
[4] L. Vigh, I. Horvath, B. Maresca, J.L. Harwood, Can the stress protein response be
controlled by ‘membrane-lipid therapy’? Trends Biochem. Sci. 32 (2007) 357.
[5] L. Vigh, B. Maresca, J.L. Harwood, Does the membrane's physical state control the
expression of heat shock and other genes? Trends Biochem. Sci. 23 (1998) 369.
[6] E. Klotzsch, G.J. Schutz, A critical survey of methods to detect plasma membrane
rafts, Philos. Trans. R. Soc. Lond. B Biol. Sci. 368 (2013) 20120033.
[7] P. Csermely, T. Korcsmaros, H.J. Kiss, G. London, R. Nussinov, Structure and dynam-
ics of molecular networks: a novel paradigm of drug discovery: a comprehensive
review, Pharmacol. Ther. 138 (2013) 333.
[8] T. Crul, N. Toth, S. Piotto, P. Literati-Nagy, K. Tory, P. Haldimann, B. Kalmar, L.
Greensmith, Z. Torok, G. Balogh, I. Gombos, F. Campana, S. Concilio, F. Gallyas, G.
Nagy, Z. Berente, B. Gungor, M. Peter, A. Glatz, A. Hunya, Z. Literati-Nagy, L. Vigh
Jr., F. Hoogstra-Berends, A. Heeres, I. Kuipers, L. Loen, J.P. Seerden, D. Zhang, R.A.
Meijering, R.H. Henning, B.J. Brundel, H.H. Kampinga, L. Koranyi, Z. Szilvassy, J.
Mandl, B. Sumegi, M.A. Febbraio, I. Horvath, P.L. Hooper, L. Vigh, Hydroximic acidderivatives: pleiotropic hsp co-inducers restoring homeostasis and robustness,
Curr. Pharm. Des. 19 (2013) 309.
[9] M. Brameshuber, J. Weghuber, V. Ruprecht, I. Gombos, I. Horvath, L. Vigh, P.
Eckerstorfer, E. Kiss, H. Stockinger, G.J. Schuetz, Imaging of mobile long-lived
nanoplatforms in the live cell plasma membrane, J. Biol. Chem. 285 (2010) 41765.
[10] T. Schmidt, G.J. Schutz, H.J. Gruber, H. Schindler, Local stoichiometries determined
by counting individual molecules, Anal. Chem. 68 (1996) 4397.
[11] D. Calebiro, F. Rieken, J.Wagner, T. Sungkaworn,U. Zabel, A. Borzi, E. Cocucci, A. Zurn,
M.J. Lohse, Single-molecule analysis of ﬂuorescently labeled G-protein-coupled re-
ceptors reveals complexes with distinct dynamics and organization, Proc. Natl.
Acad. Sci. U. S. A. 110 (2013) 743.
[12] M. Brameshuber and G.J. Schutz, Detection and quantiﬁcation of biomolecular as-
sociation in living cells using single-molecule microscopy, methods in enzymology,
vol 505: imaging and spectroscopic analysis of living cells 505 (2012) 159.
[13] M. Moertelmaier, M. Brameshuber, M. Linimeier, G.J. Schütz, H. Stockinger, Thin-
ning out clusters while conserving stoichiometry of labeling, Appl. Phys. Lett. 87
(2005) 263903.
[14] L.J. Foster, C.L. de Hoog, M. Mann, Unbiased quantitative proteomics of lipid rafts
reveals high speciﬁcity for signaling factors, Proc. Natl. Acad. Sci. U. S. A. 100
(2003) 5813.
[15] P.D. von Haller, S. Donohoe, D.R. Goodlett, R. Aebersold, J.D. Watts, Mass spectro-
metric characterization of proteins extracted from Jurkat T cell detergent-resistant
membrane domains, Proteomics 1 (2001) 1010.
[16] I. Stefanova, V. Horejsi, I.J. Ansotegui, W. Knapp, H. Stockinger, GPI-anchored
cell-surface molecules complexed to protein tyrosine kinases, Science 254
(1991) 1016.
[17] D.A. Brown, J.K. Rose, Sorting of GPI-anchored proteins to glycolipid-enriched
membrane subdomains during transport to the apical cell-surface, Cell 68 (1992)
533.
[18] K. Simons, E. Ikonen, Functional rafts in cell membranes, Nature 387 (1997)
569.
[19] D.A. Zacharias, J.D. Violin, A.C. Newton, R.Y. Tsien, Partitioning of lipid-modiﬁed
monomeric GFPs into membrane microdomains of live cells, Science 296 (2002)
913.
[20] P. Sharma, R. Varma, R.C. Sarasij, Ira, K. Gousset, G. Krishnamoorthy, M. Rao, S.
Mayor, Nanoscale organization of multiple GPI-anchored proteins in living cell
membranes, Cell 116 (2004) 577.
[21] J. Ehrig, E.P. Petrov, P. Schwille, Near-critical ﬂuctuations and cytoskeleton-assisted
phase separation lead to subdiffusion in cell membranes, Biophys. J. 100 (2011) 80.
[22] A.J. Garcia-Saez, P. Schwille, Stability of lipid domains, FEBS Lett. 584 (2010) 1653.
[23] B.B. Machta, S. Papanikolaou, J.P. Sethna, S.L. Veatch, Minimal model of plasma
membrane heterogeneity requires coupling cortical actin to criticality, Biophys. J.
100 (2011) 1668.
[24] K. Gowrishankar, S. Ghosh, S. Saha, R.C. Mayor, M. Rao, Active remodeling of corti-
cal actin regulates spatiotemporal organization of cell surface molecules, Cell 149
(2012) 1353.
[25] K.G. Suzuki, R.S. Kasai, K.M. Hirosawa, Y.L. Nemoto, M. Ishibashi, Y. Miwa, T.K.
Fujiwara, A. Kusumi, Transient GPI-anchored protein homodimers are units for
raft organization and function, Nat. Chem. Biol. 8 (2012) 774.
[26] S. Bergling, Diffusion inﬂuenced binary reactive processes in membranes involving
identical particles: a Monte Carlo study, Biophys. Chem. 56 (1995) 227.
[27] G. Adam, M. Delbrück, in: A. Rich, N. Davidson (Eds.), Reduction of dimensionality
in biological diffusion processes, W. H. Freeman, San Francisco & London, 1968,
pp. 198–215.
[28] G.I. Bell, Models for the speciﬁc adhesion of cells to cells, Science 200 (1978) 618.
[29] B. Grasberger, A.P. Minton, C. DeLisi, H. Metzger, Interaction between proteins lo-
calized in membranes, Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 6258.
[30] M.J. Swamy, L. Ciani, M. Ge, A.K. Smith, D. Holowka, B. Baird, J.H. Freed, Coexisting
domains in the plasma membranes of live cells characterized by spin-label ESR
spectroscopy, Biophys. J. 90 (2006) 4452.
[31] D.M. Owen, D.J. Williamson, A. Magenau, K. Gaus, Sub-resolution lipid domains
exist in the plasma membrane and regulate protein diffusion and distribution,
Nat. Commun. 3 (2012) 1256.
[32] M.M. Lozano, Z. Liu, E. Sunnick, A. Janshoff, K. Kumar, S.G. Boxer, Colocalization of
the ganglioside G(M1) and cholesterol detected by secondary ion mass spectrom-
etry, J. Am. Chem. Soc. 135 (2013) 5620.
[33] S.L. Veatch, P. Cicuta, P. Sengupta, A. Honerkamp-Smith, D. Holowka, B. Baird, Crit-
ical ﬂuctuations in plasma membrane vesicles, ACS Chem. Biol. 3 (2008) 287.
[34] C. Montell, The TRP superfamily of cation channels, Sci. STKE 2005 (2005) re3.
[35] N. Damann, T. Voets, B. Nilius, TRPs in our senses, Curr. Biol. 18 (2008)
R880–R889.
[36] D.E. Clapham, TRP channels as cellular sensors, Nature 426 (2003) 517.
[37] M. Tominaga, M.J. Caterina, A.B. Malmberg, T.A. Rosen, H. Gilbert, K. Skinner, B.E.
Raumann, A.I. Basbaum, D. Julius, The cloned capsaicin receptor integrates multiple
pain-producing stimuli, Neuron 21 (1998) 531.
[38] S. Brauchi, P. Orio, R. Latorre, Clues to understanding cold sensation: thermody-
namics and electrophysiological analysis of the cold receptor TRPM8, Proc. Natl.
Acad. Sci. U. S. A. 101 (2004) 15494.
[39] T. Voets, G. Droogmans, U.Wissenbach, A. Janssens, V. Flockerzi, B. Nilius, The prin-
ciple of temperature-dependent gating in cold- and heat-sensitive TRP channels,
Nature 430 (2004) 748.
[40] A. Dhaka, V. Viswanath, A. Patapoutian, Trp ion channels and temperature sensa-
tion, Annu. Rev. Neurosci. 29 (2006) 135.
[41] M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, D. Julius, The
capsaicin receptor: a heat-activated ion channel in the pain pathway, Nature 389
(1997) 816.
1613Z. Török et al. / Biochimica et Biophysica Acta 1838 (2014) 1594–1618[42] A.I. Basbaum, D.M. Bautista, G. Scherrer, D. Julius, Cellular and molecular mecha-
nisms of pain, Cell 139 (2009) 267.
[43] M.J. Caterina, Transient receptor potential ion channels as participants in
thermosensation and thermoregulation, Am. J. Physiol. Regul. Integr. Comp. Phys-
iol. 292 (2007) R64–R76.
[44] H. Watanabe, J. Vriens, S.H. Suh, C.D. Benham, G. Droogmans, B. Nilius,
Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system
and in native mouse aorta endothelial cells, J. Biol. Chem. 277 (2002) 47044.
[45] A.M. Patwardhan, A.N. Akopian, N.B. Ruparel, A. Diogenes, S.T. Weintraub, C.
Uhlson, R.C. Murphy, K.M. Hargreaves, Heat generates oxidized linoleic acid me-
tabolites that activate TRPV1 and produce pain in rodents, J. Clin. Invest. 120
(2010) 1617.
[46] E. Cao, J.F. Cordero-Morales, B. Liu, F. Qin, D. Julius, TRPV1 channels are intrinsically
heat sensitive and negatively regulated by phosphoinositide lipids, Neuron 77
(2013) 667.
[47] S. Brauchi, G. Orta, M. Salazar, E. Rosenmann, R. Latorre, A hot-sensing cold recep-
tor: C-terminal domain determines thermosensation in transient receptor poten-
tial channels, J. Neurosci. 26 (2006) 4835.
[48] D.E. Clapham, C. Miller, A thermodynamic framework for understanding tempera-
ture sensing by transient receptor potential (TRP) channels, Proc. Natl. Acad. Sci. U.
S. A. 108 (2011) 19492.
[49] T. Rohacs, C.M. Lopes, I. Michailidis, D.E. Logothetis, PI(4,5)P2 regulates the activa-
tion and desensitization of TRPM8 channels through the TRP domain, Nat.
Neurosci. 8 (2005) 626.
[50] A. Malkia, R. Madrid, V. Meseguer, E. de la Pena, M. Valero, C. Belmonte, F. Viana, Bidi-
rectional shifts of TRPM8 channel gating by temperature and chemical agents modu-
late the cold sensitivity of mammalian thermoreceptors, J. Physiol. 581 (2007) 155.
[51] A.Y. Kim, Z. Tang, Q. Liu, K.N. Patel, D. Maag, Y. Geng, X. Dong, Pirt, a
phosphoinositide-binding protein, functions as a regulatory subunit of TRPV1,
Cell 133 (2008) 475.
[52] Z. Tang, A. Kim, T. Masuch, K. Park, H.Weng, C.Wetzel, X. Dong, Pirt functions as an
endogenous regulator of TRPM8, Nat. Commun. 4 (2013) 2179.
[53] I. Dragoni, E. Guida, P. McIntyre, The cold and menthol receptor TRPM8 contains a
functionally important double cysteine motif, J. Biol. Chem. 281 (2006) 37353.
[54] M. Pertusa, R. Madrid, C. Morenilla-Palao, C. Belmonte, F. Viana, N-glycosylation of
TRPM8 ion channels modulates temperature sensitivity of cold thermoreceptor
neurons, J. Biol. Chem. 287 (2012) 18218.
[55] I. Erler, D.M. Al-Ansary, U. Wissenbach, T.F. Wagner, V. Flockerzi, B.A. Niemeyer,
Trafﬁcking and assembly of the cold-sensitive TRPM8 channel, J. Biol. Chem. 281
(2006) 38396.
[56] C. Cao, Y. Yudin, Y. Bikard, W. Chen, T. Liu, H. Li, D. Jendrossek, A. Cohen, E. Pavlov,
T. Rohacs, E. Zakharian, Polyester modiﬁcation of the mammalian TRPM8 channel
protein: implications for structure and function, Cell Rep. 4 (2013) 302.
[57] S. Bang, S. Yoo, U. Oh, S.W. Hwang, Endogenous lipid-derived ligands for sensory
TRP ion channels and their pain modulation, Arch. Pharm. Res. 33 (2010) 1509.
[58] T. Rohacs, B. Nilius, Regulation of transient receptor potential (TRP) channels by
phosphoinositides, Pﬂugers Arch. 455 (2007) 157.
[59] E. Zakharian, C. Cao, T. Rohacs, Gating of transient receptor potential melastatin 8
(TRPM8) channels activated by cold and chemical agonists in planar lipid bilayers,
J. Neurosci. 30 (2010) 12526.
[60] D.W. Hilgemann, S. Feng, C. Nasuhoglu, The complex and intriguing lives of PIP2
with ion channels and transporters, Sci. STKE 2001 (2001) re19.
[61] B.C. Suh, B. Hille, PIP2 is a necessary cofactor for ion channel function: how and
why? Annu. Rev. Biophys. 37 (2008) 175.
[62] N. Gamper, T. Rohacs, Phosphoinositide sensitivity of ion channels, a functional
perspective, Subcell. Biochem. 59 (2012) 289.
[63] B. Liu, F. Qin, Functional control of cold- and menthol-sensitive TRPM8 ion chan-
nels by phosphatidylinositol 4,5-bisphosphate, J. Neurosci. 25 (2005) 1674.
[64] E. Zakharian, B. Thyagarajan, R.J. French, E. Pavlov, T. Rohacs, Inorganic
polyphosphate modulates TRPM8 channels, PLoS One 4 (2009) e5404.
[65] R.L. Daniels, Y. Takashima, D.D. McKemy, Activity of the neuronal cold sensor
TRPM8 is regulated by phospholipase C via the phospholipid phosphoinositol
4,5-bisphosphate, J. Biol. Chem. 284 (2009) 1570.
[66] X. Zhang, S. Mak, L. Li, A. Parra, B. Denlinger, C. Belmonte, P.A. McNaughton, Direct
inhibition of the cold-activated TRPM8 ion channel by Galphaq, Nat. Cell Biol. 14
(2012) 851.
[67] E.D. Prescott, D. Julius, A modular PIP2 binding site as a determinant of capsaicin
receptor sensitivity, Science 300 (2003) 1284.
[68] R.M. Klein, C.A. Ufret-Vincenty, L. Hua, S.E. Gordon, Determinants of molecular speci-
ﬁcity in phosphoinositide regulation. Phosphatidylinositol (4,5)-bisphosphate
(PI(4,5)P2) is the endogenous lipid regulating TRPV1, J. Biol. Chem. 283 (2008) 26208.
[69] V. Lukacs, B. Thyagarajan, P. Varnai, A. Balla, T. Balla, T. Rohacs, Dual regulation of
TRPV1 by phosphoinositides, J. Neurosci. 27 (2007) 7070.
[70] F. Vanden Abeele, A. Zholos, G. Bidaux, Y. Shuba, S. Thebault, B. Beck, M.
Flourakis, Y. Panchin, R. Skryma, N. Prevarskaya, Ca2+-independent phos-
pholipase A2-dependent gating of TRPM8 by lysophospholipids, J. Biol.
Chem. 281 (2006) 40174.
[71] D.A. Andersson,M. Nash, S. Bevan,Modulation of the cold-activated channel TRPM8
by lysophospholipids and polyunsaturated fatty acids, J. Neurosci. 27 (2007) 3347.
[72] F. Vanden Abeele, A. Kondratskyi, C. Dubois, G. Shapovalov, D. Gkika, J. Busserolles,
Y. Shuba, R. Skryma, N. Prevarskaya, Complex modulation of the cold receptor
TRPM8 by volatile anaesthetics and its role in complications of general anaesthesia,
J. Cell Sci. 126 (2013) 4479.
[73] A. Nieto-Posadas, G. Picazo-Juarez, I. Llorente, A. Jara-Oseguera, S. Morales-Lazaro,
D. Escalante-Alcalde, L.D. Islas, T. Rosenbaum, Lysophosphatidic acid directly acti-
vates TRPV1 through a C-terminal binding site, Nat. Chem. Biol. 8 (2012) 78.[74] P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sorgard, M. Di, V.D.
Julius, E.D. Hogestatt, Vanilloid receptors on sensory nerves mediate the vasodila-
tor action of anandamide, Nature 400 (1999) 452.
[75] L. De Petrocellis, V. Di Marzo, Lipids as regulators of the activity of transient recep-
tor potential type V1 (TRPV1) channels, Life Sci. 77 (2005) 1651.
[76] S.W. Hwang, H. Cho, J. Kwak, S.Y. Lee, C.J. Kang, J. Jung, S. Cho, K.H. Min, Y.G. Suh, D.
Kim, U. Oh, Direct activation of capsaicin receptors by products of lipoxygenases:
endogenous capsaicin-like substances, Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6155.
[77] S. Bang, S. Yoo, T.J. Yang, H. Cho, S.W. Hwang, Farnesyl pyrophosphate is a novel
pain-producing molecule via speciﬁc activation of TRPV3, J. Biol. Chem. 285
(2010) 19362.
[78] D. Lingwood, K. Simons, Lipid rafts as a membrane-organizing principle, Science
327 (2010) 46.
[79] J.R. Martens, K. O'Connell, M. Tamkun, Targeting of ion channels to membrane mi-
crodomains: localization of KV channels to lipid rafts, Trends Pharmacol. Sci. 25
(2004) 16.
[80] S.L. Brownlow, A.G. Harper, M.T. Harper, S.O. Sage, A role for hTRPC1 and lipid raft
domains in store-mediated calcium entry in human platelets, Cell Calcium 35
(2004) 107.
[81] C. Morenilla-Palao, M. Pertusa, V. Meseguer, H. Cabedo, F. Viana, Lipid raft segrega-
tion modulates TRPM8 channel activity, J. Biol. Chem. 284 (2009) 9215.
[82] I.S. Ambudkar, S.C. Brazer, X. Liu, T. Lockwich, B. Singh, Plasma membrane localiza-
tion of TRPC channels: role of caveolar lipid rafts, Novartis Found. Symp. 258
(2004) 63.
[83] L.A. Veliz, C.A. Toro, J.P. Vivar, L.A. Arias, J. Villegas, M.A. Castro, S. Brauchi,
Near-membrane dynamics and capture of TRPM8 channels within transient con-
ﬁnement domains, PLoS One 5 (2010) e13290.
[84] Z. Bromberg, P. Goloubinoff, Y. Saidi, Y.G. Weiss, The membrane-associated tran-
sient receptor potential vanilloid channel is the central heat shock receptor control-
ling the cellular heat shock response in epithelial cells, PLoS One 8 (2013) e57149.
[85] R.M. Sapolsky, L.M. Romero, A.U. Munck, How do glucocorticoids inﬂuence stress
responses? Integrating permissive, suppressive, stimulatory, and preparative ac-
tions, Endocr. Rev. 21 (2000) 55.
[86] T.P. Mommsen, M.M. Vijayan, T.W. Moon, Cortisol in teleosts: dynamics, mecha-
nisms of action, and metabolic regulation, Rev. Fish Biol. Fish. 9 (1999) 211.
[87] K.P. Whiting, C.J. Restall, P.F. Brain, Steroid hormone-induced effects on membrane
ﬂuidity and their potential roles in non-genomicmechanisms, Life Sci. 67 (2000) 743.
[88] R.J. Borski, Nongenomic membrane actions of glucocorticoids in vertebrates,
Trends Endocrinol. Metab. 11 (2000) 427.
[89] A. Shabtay, Z. Arad, Ectothermy and endothermy: evolutionary perspectives of
thermoprotection by HSPs, J. Exp. Biol. 208 (2005) 2773.
[90] L. Dindia, E. Faught, Z. Leonenko, R. Thomas, M.M. Vijayan, Rapid cortisol signaling
in response to acute stress involves changes in plasmamembrane order in rainbow
trout liver, Am. J. Physiol. Endocrinol. Metab. 304 (2013) E1157–E1166.
[91] L. Dindia, J. Murray, E. Faught, T.L. Davis, Z. Leonenko, M.M. Vijayan, Novel
nongenomic signaling by glucocorticoid may involve changes to liver membrane
order in rainbow trout, PLoS One 7 (2012).
[92] L.E. Panin, P.V. Mokrushnikov, V.G. Kunitsyn, B.N. Zaitsev, Interaction mechanism
of cortisol and catecholamines with structural components of erythrocyte mem-
branes, J. Phys. Chem. B 114 (2010) 9462.
[93] S. Chiantia, E. London, in: E. Gulbins, I. Petrache (Eds.), Sphingolipids and Mem-
brane Domains: Recent Advances, Springer-Verlag, Wien, 2013, pp. 33–55.
[94] A.W. Meikle, S.C. West, J.A. Weed, F.H. Tyler, Single dose metyrapone test — 11
beta-hydroxylase inhibition by metyrapone and reduced metyrapone assayed by
radioimmunoassay, J. Clin. Endocrinol. Metab. 40 (1975) 290.
[95] S. Vainio, S. Heino, J.E. Mansson, P. Fredman, K. Kuismanen, O. Vaarala, E. Ikonen,
Dynamic association of human insulin receptor with lipid rafts in cells lacking ca-
veolae, EMBO Rep. 3 (2002) 95.
[96] S. LeBlanc, E. Hoglund, K.M. Gilmour, S. Currie, Hormonal modulation of the heat
shock response: insights from ﬁsh with divergent cortisol stress responses, Am. J.
Physiol. Regul. Integr. Comp. Physiol. 302 (2012) R184–R192.
[97] R. Sathiyaa, T. Campbell, M.M. Vijayan, Cortisol modulates HSP90 mRNA expres-
sion in primary cultures of trout hepatocytes, Comp. Biochem. Physiol. B Biochem.
Mol. Biol. 129 (2001) 679.
[98] A.N. Boone, M.M. Vijayan, Glucocorticoid-mediated attenuation of the hsp70 re-
sponse in trout hepatocytes involves the proteasome, Am. J. Physiol. Regul. Integr.
Comp. Physiol. 283 (2002) R680–R687.
[99] E. Nagy, Z. Balogi, I. Gombos, M. Akerfelt, A. Bjorkbom, G. Balogh, Z. Torok, A.
Maslyanko, A. Fiszer-Kierzkowska, K. Lisowska, P.J. Slotte, L. Sistonen, I. Horvath,
L. Vigh, Hyperﬂuidization-coupled membrane microdomain reorganization is
linked to activation of the heat shock response in a murine melanoma cell line,
Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 7945.
[100] B.L. Lei, D.P. Morris, M.P. Smith, D.A. Schwinn, Lipid rafts constrain basal
alpha(1A)-adrenergic receptor signaling by maintaining receptor in an inactive
conformation, Cell. Signal. 21 (2009) 1532.
[101] P.J. Butler, T.C. Tsou, J.Y.S. Li, S. Usami, S. Chien, Rate sensitivity of shear-induced
changes in the lateral diffusion of endothelial cell membrane lipids: a role for
membrane perturbation in shear-induced MAPK activation, FASEB J. 15 (2001)
216.
[102] X.Z. Wang, M.A. Khaleque, M.J. Zhao, R. Zhong, M. Gaestel, S.K. Calderwood,
Phosphorylation of HSF1 byMAPK-activated protein kinase 2 on serine 121, in-
hibits transcriptional activity and promotes HSP90 binding, J. Biol. Chem. 281
(2006) 782.
[103] M.P. Kline, R.I. Morimoto, Repression of the heat shock factor 1 transcriptional acti-
vation domain is modulated by constitutive phosphorylation, Mol. Cell. Biol. 17
(1997) 2107.
1614 Z. Török et al. / Biochimica et Biophysica Acta 1838 (2014) 1594–1618[104] U. Knauf, E.M. Newton, J. Kyriakis, R.E. Kingston, Repression of human heat shock
factor 1 activity at control temperature by phosphorylation, Genes Dev. 10
(1996) 2782.
[105] G.J. Zhang, H.W. Liu, L. Yang, Y.G. Zhong, Y.Z. Zheng, Inﬂuence of membrane phys-
ical state on the lysosomal proton permeability, J. Membr. Biol. 175 (2000) 53.
[106] M. Rossignol, T. Uso, P. Thomas, Relationship between ﬂuidity and ionic permeabil-
ity of bilayers from natural mixtures of phospholipids, J. Membr. Biol. 87 (1985)
269.
[107] D.W. Deamer, J.W. Nichols, Proton ﬂux mechanisms in model and biological mem-
branes, J. Membr. Biol. 107 (1989) 91.
[108] S.J. Marrink, F. Jahnig, H.J. Berendsen, Proton transport across transient single-ﬁle
water pores in a lipid membrane studied by molecular dynamics simulations,
Biophys. J. 71 (1996) 632.
[109] D.W. Deamer, J. Bramhall, Permeability of lipid bilayers to water and ionic solutes,
Chem. Phys. Lipids 40 (1986) 167.
[110] R. Schonherr, M. Hilger, S. Broer, R. Benz, V. Braun, Interaction of Serratia
marcescens hemolysin (ShlA) with artiﬁcial and erythrocyte membranes. Demon-
stration of the formation of aqueous multistate channels, Eur. J. Biochem. 223
(1994) 655.
[111] J.M. Wilkes, H.J. Ballard, D.T. Dryden, B.H. Hirst, Proton permeability and lipid dy-
namics of gastric and duodenal apical membrane vesicles, Am. J. Physiol. 256
(1989) G553–G562.
[112] O. Schroder, W. Rathner, W.F. Caspary, J. Stein, Bile acid-induced increase of rat co-
lonic apical membrane ﬂuidity and proton permeability, Z. Gastroenterol. 34
(1996) 365.
[113] G. Balogh, I. Horvath, E. Nagy, Z. Hoyk, S. Benko, O. Bensaude, L. Vigh, The
hyperﬂuidization of mammalian cell membranes acts as a signal to initiate the
heat shock protein response, FEBS J. 272 (2005) 6077.
[114] G. Balogh, G. Maulucci, I. Gombos, I. Horvath, Z. Torok, M. Peter, E. Fodor, T. Pali,
S. Benko, T. Parasassi, S.M. De, J.L. Harwood, L. Vigh, Heat stress causes
spatially-distinct membrane re-modelling in K562 leukemia cells, PLoS One 6
(2011) e21182.
[115] H. Tsuchiya, Structure-speciﬁc membrane-ﬂuidizing effect of propofol, Clin. Exp.
Pharmacol. Physiol. 28 (2001) 292.
[116] E.H. Mojumdar, A.P. Lyubartsev, Molecular dynamics simulations of local anesthet-
ic articaine in a lipid bilayer, Biophys. Chem. 153 (2010) 27.
[117] W. Kopec, J. Telenius, H. Khandelia, Molecular dynamics simulations of the interac-
tions of medicinal plant extracts and drugs with lipid bilayer membranes, FEBS J.
280 (2013) 2785.
[118] M. Darvas, P.N. Hoang, S. Picaud, M. Sega, P. Jedlovszky, Anesthetic molecules em-
bedded in a lipid membrane: a computer simulation study, Phys. Chem. Chem.
Phys. 14 (2012) 12956.
[119] Z. Torok, N.M. Tsvetkova, G. Balogh, I. Horvath, E. Nagy, Z. Penzes, J. Hargitai, O.
Bensaude, P. Csermely, J.H. Crowe, B. Maresca, L. Vigh, Heat shock protein
coinducers with no effect on protein denaturation speciﬁcally modulate the mem-
brane lipid phase, Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3131.
[120] S. Piotto, S. Concilio, P. Iannelli, Modelling of lipid membranes and membrane
interacting compounds, Chemistry and Physics of Lipids, vol. 143, Elsevier,
Ireland, 2006, pp. 62–63.
[121] E. Krieger, T. Darden, S.B. Nabuurs, A. Finkelstein, G. Vriend, Making optimal use of
empirical energy functions: force-ﬁeld parameterization in crystal space, Proteins
57 (2004) 678.
[122] H.J.C. Berendsen, J.P.M. Postma, W.F. Vangunsteren, A. Dinola, J.R. Haak,
Molecular-dynamicswith coupling to an external bath, J. Chem. Phys. 81 (1984) 3684.
[123] Y. Duan, C. Wu, S. Chowdhury, M.C. Lee, G.M. Xiong, W. Zhang, R. Yang, P. Cieplak,
R. Luo, T. Lee, J. Caldwell, J.M. Wang, P. Kollman, A point-charge force ﬁeld for mo-
lecular mechanics simulations of proteins based on condensed-phase quantum
mechanical calculations, J. Comput. Chem. 24 (2003) 1999.
[124] A. Klamt, Conductor-like screeningmodel for real solvents— a new approach to the
quantitative calculation of solvation phenomena, J. Phys. Chem. 99 (1995) 2224.
[125] J.J.P. Stewart, Special Issue –Mopac – a semiempirical molecular-orbital program, J.
Comput. Aided Mol. Des. 4 (1990) 1.
[126] U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, L.G. Pedersen, A smooth
particle mesh Ewald method, J. Chem. Phys. 103 (1995) 8577.
[127] I. Gombos, T. Crul, S. Piotto, B. Gungor, Z. Torok, G. Balogh, M. Peter, J.P. Slotte, F.
Campana, A.M. Pilbat, A. Hunya, N. Toth, Z. Literati-Nagy, L. Vigh Jr., A. Glatz, M.
Brameshuber, G.J. Schutz, A. Hevener, M.A. Febbraio, I. Horvath, L. Vigh,
Membrane-lipid therapy in operation: the HSP co-inducer BGP-15 activates stress
signal transduction pathways by remodeling plasma membrane rafts, PLoS One 6
(2011) e28818.
[128] H.M. Shapiro, Practical Flow Cytometry, Wiley-Liss, New York, 1995.
[129] J.W. Bigger, Treatment of staphylococcal infections with penicillin by intermittent
sterilisation, Lancet 2 (1944) 497.
[130] S.V. Avery,Microbial cell individuality and the underlying sources of heterogeneity,
Nat. Rev. Microbiol. 4 (2006) 577.
[131] T.T. Le, J.X. Cheng, Single-cell proﬁling reveals the origin of phenotypic variability
in adipogenesis, PLoS One 4 (2009).
[132] J.M. Levsky, S.M. Shenoy, R.C. Pezo, R.H. Singer, Single-cell gene expression proﬁl-
ing, Science 297 (2002) 836.
[133] I.R. Booth, Stress and the single cell: intrapopulation diversity is a mechanism to
ensure survival upon exposure to stress, Int. J. Food Microbiol. 78 (2002) 19.
[134] H. Steels, S.A. James, I.N. Roberts, M. Stratford, Sorbic acid resistance: the inoculum
effect, Yeast 16 (2000) 1173.
[135] P.V. Attﬁeld, H.Y. Choi, D.A. Veal, P.J. Bell, Heterogeneity of stress gene expression
and stress resistance among individual cells of Saccharomyces cerevisiae, Mol.
Microbiol. 40 (2001) 1000.[136] E.R. Sumner, S.V. Avery, Phenotypic heterogeneity: differential stress resistance
among individual cells of the yeast Saccharomyces cerevisiae, Microbiology 148
(2002) 345.
[137] S.L. Rutherford, S. Lindquist, Hsp90 as a capacitor for morphological evolution, Na-
ture 396 (1998) 336.
[138] A. Bergman, M.L. Siegal, Evolutionary capacitance as a general feature of complex
gene networks, Nature 424 (2003) 549.
[139] K.Holmstrom, T. Tolker-Nielsen, S.Molin, Physiological states of individual Salmonella
Typhimurium cells monitored by in situ reverse transcription-PCR, J. Bacteriol. 181
(1999) 1733.
[140] J. Plesset, J.R. Ludwig, B.S. Cox, C.S. Mclaughlin, Effect of cell-cycle position on ther-
motolerance in Saccharomyces-cerevisiae, J. Bacteriol. 169 (1987) 779.
[141] M. Jacquet, G. Renault, S. Lallet, J. De Mey, A. Goldbeter, Oscillatory
nucleocytoplasmic shuttling of the general stress response transcriptional activa-
tors Msn2 and Msn4 in Saccharomyces cerevisiae, J. Cell Biol. 161 (2003) 497.
[142] B.P. Tu, A. Kudlicki, M. Rowicka, S.L. McKnight, Logic of the yeast metabolic
cycle: temporal compartmentalization of cellular processes, Science 310
(2005) 1152.
[143] H. Tonozuka, J.Q. Wang, K. Mitsui, T. Saito, Y. Hamada, K. Tsurugi, Analysis of the
upstream regulatory region of the GTS1 gene required for its oscillatory expres-
sion, J. Biochem. 130 (2001) 589.
[144] J.Q.Wang,W.D. Liu, T. Uno, H. Tonozuka, K. Mitsui, K. Tsurugi, Cellular stress re-
sponses oscillate in synchronization with the ultradian oscillation of energy
metabolism in the yeast Saccharomyces cerevisiae, FEMS Microbiol. Lett. 189
(2000) 9.
[145] J.A. Flattery-O'Brien, I.W. Dawes, Hydrogen peroxide causes RAD9-dependent cell
cycle arrest in G2 in Saccharomyces cerevisiaewhereas menadione causes G1 arrest
independent of RAD9 function, J. Biol. Chem. 273 (1998) 8564.
[146] D. Hong, D. Jaron, D.G. Buerk, K.A. Barbee, Heterogeneous response of microvascu-
lar endothelial cells to shear stress, Am. J. Physiol. Heart Circ. Physiol. 290 (2006)
H2498–H2508.
[147] L. Vigh, P.V. Escriba, A. Sonnleitner, M. Sonnleitner, S. Piotto, B. Maresca,
I. Horvath, J.L. Harwood, The signiﬁcance of lipid composition for membrane
activity: new concepts and ways of assessing function, Prog. Lipid Res. 44
(2005) 303.
[148] C. Boutin, Y. Roche, C. Millot, R. Deturche, P. Royer, M. Manfait, J. Plain, P.
Jeannesson, J.M. Millot, R. Jafﬁol, High heterogeneity of plasma membrane
microﬂuidity in multidrug-resistant cancer cells, J. Biomed. Opt. 14 (2009).
[149] A.E. Carpenter, T.R. Jones, M.R. Lamprecht, C. Clarke, I.H. Kang, O. Friman, D.A.
Guertin, J.H. Chang, R.A. Lindquist, J. Moffat, P. Golland, D.M. Sabatini, CellProﬁler:
image analysis software for identifying and quantifying cell phenotypes, Genome
Biol. 7 (2006).
[150] G. Balogh, M. Peter, A. Glatz, I. Gombos, Z. Torok, I. Horvath, J.L. Harwood, L. Vigh,
Key role of lipids in heat stress management, FEBS Lett. 587 (2013) 1970.
[151] M. Lagarde, N. Bernoud-Hubac, M. Guichardant, Expanding the horizons of
lipidomics. Towards ﬂuxolipidomics, Mol. Membr. Biol. 29 (2012) 222.
[152] X.L. Han, K. Yang, R.W. Gross, Multi-dimensional mass spectrometry-based shot-
gun lipidomics and novel strategies for lipidomic analyses, Mass Spectrom. Rev.
31 (2012) 134.
[153] B. Zanolari, S. Friant, K. Funato, C. Sutterlin, B.J. Stevenson, H. Riezman, Sphingoid
base synthesis requirement for endocytosis in Saccharomyces cerevisiae, EMBO J.
19 (2000) 2824.
[154] R.C. Dickson, E.E. Nagiec, M. Skrzypek, P. Tillman, G.B. Wells, R.L. Lester,
Sphingolipids are potential heat stress signals in Saccharomyces, J. Biol. Chem.
272 (1997) 30196.
[155] G.M. Jenkins, A. Richards, T. Wahl, C.G. Mao, L. Obeid, Y. Hannun, Involvement of
yeast sphingolipids in the heat stress response of Saccharomyces cerevisiae, J. Biol.
Chem. 272 (1997) 32566.
[156] L.A. Cowart, Y.A. Hannun, Using genomic and lipidomic strategies to investigate
sphingolipid function in the yeast heat-stress response, Biochem. Soc. Trans. 33
(2005) 1166.
[157] H.S. Vu, P. Tamura, N.A. Galeva, R. Chaturvedi, M.R. Roth, T.D. Williams, X. Wang, J.
Shah, R. Welti, Direct infusion mass spectrometry of oxylipin-containing
Arabidopsis membrane lipids reveals varied patterns in different stress responses,
Plant Physiol. 158 (2012) 324.
[158] T. Munnik, J.E. Vermeer, Osmotic stress-induced phosphoinositide and inositol
phosphate signalling in plants, Plant Cell Environ. 33 (2010) 655.
[159] S.A. Arisz, R. van Wijk, W. Roels, J.K. Zhu, M.A. Haring, T. Munnik, Rapid phospha-
tidic acid accumulation in response to low temperature stress in Arabidopsis is gen-
erated through diacylglycerol kinase, Front. Plant Sci. 4 (2013) 1.
[160] I. Horvath, A. Glatz, H. Nakamoto,M.L. Mishkind, T. Munnik, Y. Saidi, P. Goloubinoff,
J.L. Harwood, L. Vigh, Heat shock response in photosynthetic organisms: mem-
brane and lipid connections, Prog. Lipid Res. 51 (2012) 208.
[161] G. Balogh, M. Peter, G. Liebisch, I. Horvath, Z. Torok, E. Nagy, A. Maslyanko, S.
Benko, G. Schmitz, J.L. Harwood, L. Vigh, Lipidomics reveals membrane lipid re-
modelling and release of potential lipid mediators during early stress responses
in a murine melanoma cell line, Biochim. Biophys. Acta 1801 (2010) 1036.
[162] M. Peter, G. Balogh, I. Gombos, G. Liebisch, I. Horvath, Z. Torok, E. Nagy, A.
Maslyanko, S. Benko, G. Schmitz, J.L. Harwood, L. Vigh, Nutritional lipid supply
can control the heat shock response of B16 melanoma cells in culture, Mol.
Membr. Biol. 29 (2012) 274.
[163] L. Vigh, Z. Torok, G. Balogh, A. Glatz, S. Piotto, I. Horvath, Membrane-regulated
stress response: a theoretical and practical approach, Adv. Exp. Med. Biol. 594
(2007) 114.
[164] G. van Meer, B.R. Leeﬂang, G. Liebisch, G. Schmitz, F.M. Goni, The European
lipidomics initiative: enabling technologies, Methods Enzymol. 432 (2007) 213.
1615Z. Török et al. / Biochimica et Biophysica Acta 1838 (2014) 1594–1618[165] M. Akerfelt, R.I. Morimoto, L. Sistonen, Heat shock factors: integrators of cell stress,
development and lifespan, Nat. Rev. Mol. Cell Biol. 11 (2010) 545.
[166] A. Sandqvist, J.K. Bjork, M. Akerfelt, Z. Chitikova, A. Grichine, C. Vourc'h, C. Jolly, T.A.
Salminen, Y. Nymalm, L. Sistonen, Heterotrimerization of heat-shock factors 1 and
2 provides a transcriptional switch in response to distinct stimuli, Mol. Biol. Cell 20
(2009) 1340.
[167] J. Anckar, L. Sistonen, Regulation of HSF1 function in the heat stress response: im-
plications in aging and disease, Annu. Rev. Biochem. 80 (2011) 1089.
[168] S. Lambert, D. Vind-Kezunovic, S. Karvinen, R. Gniadecki, Ligand-independent
activation of the EGFR by lipid raft disruption, J. Invest. Dermatol. 126 (2006)
954.
[169] U. Coskun, M. Grzybek, D. Drechsel, K. Simons, Regulation of human EGF receptor
by lipids, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 9044.
[170] P.V. Escriba, J.M. Gonzalez-Ros, F.M. Goni, P.K. Kinnunen, L. Vigh, L.
Sanchez-Magraner, A.M. Fernandez, X. Busquets, I. Horvath, G. Barcelo-Coblijn,
Membranes: a meeting point for lipids, proteins and therapies, J. Cell. Mol. Med.
12 (2008) 829.
[171] S.M. Liu, G. Carpenter, Activity of the epidermal-growth-factor receptor and phos-
pholipase C-gamma 1 in heat-stressed ﬁbroblasts and A-431 cells, Biochem. J. 286
(Pt 2) (1992) 541.
[172] S.K. Calderwood, M.A. Stevenson, Inducers of the heat shock response stimulate
phospholipase C and phospholipase A2 activity in mammalian cells, J. Cell. Physiol.
155 (1993) 248.
[173] G. Kadamur, E.M. Ross, Mammalian phospholipase C, Annu. Rev. Physiol. 75 (2013)
127.
[174] S.Z. Zheng, Y.L. Liu, B. Li, Z.L. Shang, R.G. Zhou, D.Y. Sun, Phosphoinositide-speciﬁc
phospholipase C9 is involved in the thermotolerance of Arabidopsis, Plant J. 69
(2012) 689.
[175] C.I. Holmberg, V. Hietakangas, A. Mikhailov, J.O. Rantanen, M. Kallio, A. Meinander,
J. Hellman, N. Morrice, C. MacKintosh, R.I. Morimoto, J.E. Eriksson, L. Sistonen,
Phosphorylation of serine 230 promotes inducible transcriptional activity of heat
shock factor 1, EMBO J. 20 (2001) 3800.
[176] G. Labar, J. Wouters, D.M. Lambert, A review on themonoacylglycerol lipase: at the
interface between fat and endocannabinoid signalling, Curr. Med. Chem. 17 (2010)
2588.
[177] M. Reisenberg, P.K. Singh, G.Williams, P. Doherty, The diacylglycerol lipases: struc-
ture, regulation and roles in and beyond endocannabinoid signalling, Philos. Trans.
R. Soc. Lond. B Biol. Sci. 367 (2012) 3264.
[178] D.B. van Rossum, R.L. Patterson, PKC and PLA2: probing the complexities of the cal-
cium network, Cell Calcium 45 (2009) 535.
[179] D.A. Jurivich, L. Sistonen, K.D. Sarge, R.I. Morimoto, Arachidonate is a potent mod-
ulator of human heat shock gene transcription, Proc. Natl. Acad. Sci. U. S. A. 91
(1994) 2280.
[180] S. Ishikura, A. Koshkina, A. Klip, Small G proteins in insulin action: Rab and Rho
families at the crossroads of signal transduction and GLUT4 vesicle trafﬁc, Acta
Physiol. (Oxf.) 192 (2008) 61.
[181] O.S. Bang, B.G. Ha, E.K. Park, S.S. Kang, Activation of Akt is induced by heat shock
and involved in suppression of heat-shock-induced apoptosis of NIH3T3 cells,
Biochem. Biophys. Res. Commun. 278 (2000) 306.
[182] S.D. Chou, T. Prince, J. Gong, S.K. Calderwood, mTOR is essential for the proteotoxic
stress response, HSF1 activation and heat shock protein synthesis, PLoS One 7
(2012) e39679.
[183] S.I. Han, S.Y. Oh, S.H. Woo, K.H. Kim, J.H. Kim, H.D. Kim, H.S. Kang, Implication of a
small GTPase Rac1 in the activation of c-Jun N-terminal kinase and heat shock fac-
tor in response to heat shock, J. Biol. Chem. 276 (2001) 1889.
[184] R.Z. Lin, Z.W. Hu, J.H. Chin, B.B. Hoffman, Heat shock activates c-Src tyrosine ki-
nases and phosphatidylinositol 3-kinase in NIH3T3 ﬁbroblasts, J. Biol. Chem. 272
(1997) 31196.
[185] P. Holzer, The pharmacological challenge to tame the transient receptor potential
vanilloid-1 (TRPV1) nocisensor, Br. J. Pharmacol. 155 (2008) 1145.
[186] Y. Chang, A. Abe, J.A. Shayman, Ceramide formationduringheat shock: a potentialme-
diator of alpha B-crystallin transcription, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 12275.
[187] C.A. Dumitru, A. Carpinteiro, T. Trarbach, U.R. Hengge, E. Gulbins, Doxorubicin en-
hances TRAIL-induced cell death via ceramide-enriched membrane platforms, Ap-
optosis 12 (2007) 1533.
[188] P.A. Lang, M. Schenck, J.P. Nicolay, J.U. Becker, D.S. Kempe, A. Lupescu, S. Koka, K.
Eisele, B.A. Klarl, H. Rubben, K.W. Schmid, K. Mann, S. Hildenbrand, H. Hefter,
S.M. Huber, T. Wieder, A. Erhardt, D. Haussinger, E. Gulbins, F. Lang, Liver cell
death and anemia in Wilson disease involve acid sphingomyelinase and ceramide,
Nat. Med. 13 (2007) 164.
[189] Y.H. Zeidan, Y.A. Hannun, Activation of acid sphingomyelinase by protein kinase
Cdelta-mediated phosphorylation, J. Biol. Chem. 282 (2007) 11549.
[190] Y.A. Hannun, L.M. Obeid, Principles of bioactive lipid signalling: lessons from
sphingolipids, Nat. Rev. Mol. Cell Biol. 9 (2008) 139.
[191] C. Mao, L.M. Obeid, Ceramidases: regulators of cellular responses mediated by cer-
amide, sphingosine, and sphingosine-1-phosphate, Biochim. Biophys. Acta 1781
(2008) 424.
[192] O. Kozawa, K. Tanabe, H. Ito, H. Matsuno, M. Niwa, K. Kato, T. Uematsu, Sphingosine
1-phosphate regulates heat shock protein 27 induction by a p38 MAP
kinase-dependent mechanism in aortic smooth muscle cells, Exp. Cell Res. 250
(1999) 376.
[193] S. Takai, H. Tokuda, R. Matsushima-Nishiwaki, Y. Hanai, K. Kato, O. Kozawa, Phos-
phatidylinositol 3-kinase/Akt plays a role in sphingosine 1-phosphate-stimulated
HSP27 induction in osteoblasts, J. Cell. Biochem. 98 (2006) 1249.
[194] H. Akiyama, N. Sasaki, S. Hanazawa, M. Gotoh, S. Kobayashi, Y. Hirabayashi, K.
Murakami-Murofushi, Novel sterol glucosyltransferase in the animal tissue andcultured cells: evidence that glucosylceramide as glucose donor, Biochim. Biophys.
Acta 1811 (2011) 314.
[195] S. Kunimoto, T. Kobayashi, S. Kobayashi, K. Murakami-Murofushi, Expression of
cholesteryl glucoside by heat shock in human ﬁbroblasts, Cell Stress Chaperones
5 (2000) 3.
[196] H. Grassme, J. Riethmuller, E. Gulbins, Biological aspects of ceramide-enriched
membrane domains, Prog. Lipid Res. 46 (2007) 161.
[197] F.A. Mathieson, G.F. Nixon, Sphingolipids differentially regulate mitogen-activated
protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB
activation, Br. J. Pharmacol. 147 (2006) 351.
[198] S. Kunimoto, W. Murofushi, H. Kai, Y. Ishida, A. Uchiyama, T. Kobayashi, S.
Kobayashi, H. Murofushi, K. Murakami-Murofushi, Steryl glucoside is a lipid medi-
ator in stress-responsive signal transduction, Cell Struct. Funct. 27 (2002) 157.
[199] F. Cajone, M. Crescente, In vitro activation of heat shock transcription factor by
4-hydroxynonenal, Chem. Biol. Interact. 84 (1992) 97.
[200] A.T. Jacobs, L.J.Marnett, Heat shock factor 1 attenuates4-Hydroxynonenal-mediated
apoptosis: critical role for heat shock protein 70 induction and stabilization of
Bcl-XL, J. Biol. Chem. 282 (2007) 33412.
[201] P. Chaudhary, R. Sharma, A. Sharma, R. Vatsyayan, S. Yadav, S.S. Singhal, N. Rauniyar,
L. Prokai, S. Awasthi, Y.C. Awasthi, Mechanisms of 4-hydroxy-2-nonenal induced
pro- and anti-apoptotic signaling, Biochemistry 49 (2010) 6263.
[202] R. Sharma, A. Sharma, S. Dwivedi, P. Zimniak, S. Awasthi, Y.C. Awasthi,
4-Hydroxynonenal self-limits fas-mediated DISC-independent apoptosis by pro-
moting export of Daxx from the nucleus to the cytosol and its binding to Fas, Bio-
chemistry 47 (2008) 143.
[203] D.S. Ryu, H. Yang, S.E. Lee, C.S. Park, Y.H. Jin, Y.S. Park, Crotonaldehyde induces heat
shock protein 72 expression that mediates anti-apoptotic effects in human endo-
thelial cells, Toxicol. Lett. 223 (2013) 116.
[204] B. Metzler, R. Abia, M. Ahmad, F. Wernig, O. Pachinger, Y. Hu, Q. Xu, Activation of
heat shock transcription factor 1 in atherosclerosis, Am. J. Pathol. 162 (2003) 1669.
[205] G. Schett, K. Redlich, Q. Xu, P. Bizan, M. Groger, M. Tohidast-Akrad, H. Kiener, J.
Smolen, G. Steiner, Enhanced expression of heat shock protein 70 (hsp70) and
heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue.
Differential regulation of hsp70 expression and hsf1 activation in synovial ﬁ-
broblasts by proinﬂammatory cytokines, shear stress, and antiinﬂammatory
drugs, J. Clin. Invest. 102 (1998) 302.
[206] J. Hargitai, H. Lewis, I. Boros, T. Racz, A. Fiser, I. Kurucz, I. Benjamin, L. Vigh, Z.
Penzes, P. Csermely, D.S. Latchman, Bimoclomol, a heat shock protein co-inducer,
acts by the prolonged activation of heat shock factor-1, Biochem. Biophys. Res.
Commun. 307 (2003) 689.
[207] S.D. Westerheide, J. Anckar, S.M. Stevens Jr., L. Sistonen, R.I. Morimoto,
Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1, Science
323 (2009) 1063.
[208] L. Vigh, I. Horvath, T. Farkas, L.I. Horvath, A. Belea, Adaptation of membrane ﬂuidity
of rye and wheat seedlings according to temperature, Phytochemistry 18 (1979)
787.
[209] Y. Saidi, M. Peter, A. Finka, C. Cicekli, L. Vigh, P. Goloubinoff, Membrane lipid com-
position affects plant heat sensing and modulates Ca (2+)-dependent heat shock
response, Plant Signal. Behav. 5 (2010).
[210] L. Vigh, B. Maresca, Dual Role of Membranes in Heat Stress: As Thermosensors
They Modulate the Expression of Stress Genes and by Interacting With Stress Pro-
teins, They Reorganize Their Own Lipid Order and Functionality, in: K.B. Storey,
J.M. Storey (Eds.), Elsevier, Amsterdam, 2002, pp. 173–178.
[211] A.R. Cossins, P.A. Murray, A.Y. Gracey, J. Logue, S. Polley, M. Caddick, S. Brooks, T.
Postle, N. Maclean, The role of desaturases in cold-induced lipid restructuring,
Biochem. Soc. Trans. 30 (2002) 1082.
[212] L. Carratu, S. Franceschelli, C.L. Pardini, G.S. Kobayashi, I. Horvath, L. Vigh, B.
Maresca, Membrane lipid perturbation modiﬁes the set point of the
temperature of heat shock response in yeast, Proc. Natl. Acad. Sci. U. S. A.
93 (1996) 3870.
[213] R. Mittler, A. Finka, P. Goloubinoff, How do plants feel the heat? Trends Biochem.
Sci. 37 (2012) 118.
[214] N. Shigapova, Z. Torok, G. Balogh, P. Goloubinoff, L. Vigh, I. Horvath, Membrane ﬂu-
idization triggers membrane remodeling which affects the thermotolerance in
Escherichia coli, Biochem. Biophys. Res. Commun. 328 (2005) 1216.
[215] R.B. Wang, J.T. Kovalchin, P. Muhlenkamp, R.Y. Chandawarkar, Exogenous heat
shock protein 70 binds macrophage lipid raft microdomain and stimulates
phagocytosis, processing, and MHC-II presentation of antigens, Blood 107
(2006) 1636.
[216] A.H. Broquet, G. Thomas, J. Masliah, G. Trugnan, M. Bachelet, Expression of the mo-
lecular chaperone Hsp70 in detergent-resistant microdomains correlates with its
membrane delivery and release, J. Biol. Chem. 278 (2003) 21601.
[217] A. Porta, Z. Torok, I. Horvath, S. Franceschelli, L. Vigh, B. Maresca, Genetic modiﬁca-
tion of the Salmonellamembrane physical state alters the pattern of heat shock re-
sponse, J. Bacteriol. 192 (2010) 1988.
[218] S. Panpoom, D.A. Los, N. Murata, Biochemical characterization of a delta12
acyl-lipid desaturase after overexpression of the enzyme in Escherichia coli,
Biochim. Biophys. Acta 1390 (1998) 323.
[219] K. Yamamoto, J. Ando, Endothelial cell and model membranes respond to shear
stress by rapidly decreasing the order of their lipid phases, J. Cell Sci. 126 (2013)
1227.
[220] A.S. Janoff, A. Haug, E.J. Mcgroarty, Relationship of growth temperature and ther-
motropic lipid phase-changes in cytoplasmic and outer membranes from
Escherichia-coli-K12, Biochim. Biophys. Acta 555 (1979) 56.
[221] A. deMarco, L. Vigh, S. Diamant, P. Goloubinoff, Native folding of aggregation-prone
recombinant proteins in Escherichia coli by osmolytes, plasmid- or benzyl
1616 Z. Török et al. / Biochimica et Biophysica Acta 1838 (2014) 1594–1618alcohol-overexpressed molecular chaperones, Cell Stress Chaperones 10 (2005)
329.
[222] J.T. Stults, Matrix-assisted laser-desorption ionization mass-spectrometry
(MALDI-MS), Curr. Opin. Struct. Biol. 5 (1995) 691.
[223] M. Yanagida, Y. Miura, K. Yagasaki, M. Taoka, T. Isobe, N. Takahashi, Matrix
assisted laser desorption/ionization-time of ﬂight-mass spectrometry analysis of
proteins detected by anti-phosphotyrosine antibody on two-dimensional-gels of
ﬁbrolast cell lysates after tumor necrosis factor-alpha stimulation, Electrophoresis
21 (2000) 1890.
[224] N.M. Tsvetkova, I. Horvath, Z. Torok, W.F. Wolkers, Z. Balogi, N. Shigapova, L.M.
Crowe, F. Tablin, E. Vierling, J.H. Crowe, L. Vigh, Small heat-shock proteins regulate
membrane lipid polymorphism, Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13504.
[225] J.J. Bijlsma, E.A. Groisman, The PhoP/PhoQ system controls the intramacrophage
type three secretion system of Salmonella enterica, Mol. Microbiol. 57 (2005) 85.
[226] J.S. Gunn, The Salmonella PmrAB regulon: lipopolysaccharide modiﬁcations, anti-
microbial peptide resistance and more, Trends Microbiol. 16 (2008) 284.
[227] A. Porta, A. Eletto, Z. Torok, S. Franceschelli, A. Glatz, L. Vigh, B. Maresca, Changes in
membrane ﬂuid state and heat shock response cause attenuation of virulence, J.
Bacteriol. 192 (2010) 1999.
[228] P. Launois, F. Tacchini-Cottier, M.P. Kieny, Cutaneous leishmaniasis: progress to-
wards a vaccine, Expert Rev. Vaccines 7 (2008) 1277.
[229] J. Kur, L. Holec-Gasior, E. Hiszczynska-Sawicka, Current status of toxoplasmosis
vaccine development, Expert Rev. Vaccines 8 (2009) 791.
[230] M.F. Good, J.M. Reiman, I.B. Rodriguez, K. Ito, S.K. Yanow, I.M. El-Deeb,M.R. Batzloff,
D.I. Stanisic, C. Engwerda, T. Spithill, S.L. Hoffman, M. Lee, V. McPhun, Cross-species
malaria immunity induced by chemically attenuated parasites, J. Clin. Investig. 123
(2013) 3353.
[231] S. Gargano, G. Dilallo, G.S. Kobayashi, B. Maresca, A temperature-sensitive strain of
histoplasma-capsulatum has an altered delta(9)-fatty acid desaturase gene, Lipids
30 (1995) 899.
[232] R. Allendoerfer, B. Maresca, G.S. Deepe, Cellular immune responses to recombinant
heat shock protein 70 from Histoplasma capsulatum, Infect. Immun. 64 (1996)
4123.
[233] B. Maresca, G.S. Kobayashi, Hsp70 in parasites— as an inducible protective protein
and as an antigen, Experientia 50 (1994) 1067.
[234] X. Tu, T. Latiﬁ, A. Bougdour, S. Gottesman, E.A. Groisman, The PhoP/PhoQ
two-component system stabilizes the alternative sigma factor RpoS in Salmonella
enterica, Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 13503.
[235] E.A. Groisman, H. Ochman, How Salmonella became a pathogen, Trends Microbiol.
5 (1997) 343.
[236] F. Ritossa, A new pufﬁng pattern induced by temperature shock and DNP in Dro-
sophila, Experientia 18 (1962) 571.
[237] M.F. Barbe, M. Tytell, D.J. Gower, W.J. Welch, Hyperthermia protects against light
damage in the rat retina, Science 241 (1988) 1817.
[238] B.M. Gulluoglu, B.S. Aksoy, E.S. Ozveri, M. Yuksel, E.E. Demiralp, A.O. Aktan, Optimal
timing and temperature for hyperthermic preconditioning in an animal model of
fecal peritonitis, J. Invest. Surg. 15 (2002) 117.
[239] H. Xu, M. Aibiki, J. Nagoya, Neuroprotective effects of hyperthermic precondition-
ing on infarcted volume after middle cerebral artery occlusion in rats: role of aden-
osine receptors, Crit. Care Med. 30 (2002) 1126.
[240] N. Yamashita, S. Hoshida, N. Taniguchi, T. Kuzuya, M. Hori, Whole-body hyperther-
mia provides biphasic cardioprotection against ischemia/reperfusion injury in the
rat, Circulation 98 (1998) 1414.
[241] M. Oba, M.A. Suico, S. Morino, S. Yano, T. Matsuno, T. Koga, T. Sato, T. Shuto, H. Kai,
Modiﬁedmild heat shockmodality attenuates hepatic ischemia/reperfusion injury,
J. Surg. Res. 162 (2010) 213.
[242] Y. Harder, M. Amon, M.W. Laschke, R. Schramm, M. Rucker, R. Wettstein, J.
Bastiaanse, A. Frick, H.G. Machens, M. Kuntscher, G. Germann, B. Vollmar, D. Erni,
M.D. Menger, An old dream revitalised: preconditioning strategies to protect sur-
gical ﬂaps from critical ischaemia and ischaemia–reperfusion injury, J. Plast.
Reconstr. Aesthet. Surg. 61 (2008) 503.
[243] K.J. Mulhall, R. McLaughlin, E. Kay, P. Kiely, D. Bouchier-Hayes, P. Murray, Thermal
preconditioning prevents peritendinous adhesions and inﬂammation, Clin. Orthop.
Relat. Res. (2002) 258.
[244] G.A. Perdrizet, T.G. Heffron, F.C. Buckingham, P.J. Salciunas, A.O. Gaber, F.P. Stuart,
J.R. Thistlethwaite, Stress conditioning: a novel approach to organ preservation,
Curr. Surg. 46 (1989) 23.
[245] A. Rabini, D.B. Piazzini, G. Tancredi, C. Foti, G. Milano, G. Ronconi, A. Specchia, P.E.
Ferrara, L. Maggi, E. Amabile, M. Galli, R. Bernabei, C. Bertolini, E. Marzetti, Deep
heating therapy via microwave diathermy relieves pain and improves physical
function in patients with knee osteoarthritis: a double-blind randomized clinical
trial, Eur. J. Phys. Rehabil. Med. 48 (2012) 549.
[246] S. Kokura, S. Adachi, E. Manabe, K. Mizushima, T. Hattori, T. Okuda, N. Nakabe, O.
Handa, T. Takagi, Y. Naito, N. Yoshida, T. Yoshikawa,Whole body hyperthermia im-
proves obesity-induced insulin resistance in diabetic mice, Int. J. Hyperth. 23
(2007) 259.
[247] P.L. Hooper, Hot-tub therapy for type 2 diabetes mellitus, N. Engl. J. Med. 341
(1999) 924.
[248] M.E. Mikucki, D.T. Fisher, A.W. Ku, M.M. Appenheimer, J.B. Muhitch, S.S. Evans, Pre-
conditioning thermal therapy: ﬂipping the switch on IL-6 for anti-tumour immuni-
ty, Int. J. Hyperth. 29 (2013) 464.
[249] A. Murshid, T. Eguchi, S.K. Calderwood, Stress proteins in aging and life span, Int. J.
Hyperth. 29 (2013) 442.
[250] S. Schroeder, C. Lindemann, A. Hoeft, C. Putensen, D. Decker, A.A. von Ruecker, F.
Stuber, Impaired inducibility of heat shock protein 70 in peripheral blood lympho-
cytes of patients with severe sepsis, Crit. Care Med. 27 (1999) 1080.[251] Y.G. Weiss, A. Bouwman, B. Gehan, G. Schears, N. Raj, C.S. Deutschman, Cecal liga-
tion and double puncture impairs heat shock protein 70 (HSP-70) expression in
the lungs of rats, Shock 13 (2000) 19.
[252] X.B. Duan, F. Berthiaume, D. Yarmush, M.L. Yarmush, Proteomic analysis of altered
protein expression in skeletal muscle of rats in a hypermetabolic state induced by
burn sepsis, Biochem. J. 397 (2006) 149.
[253] Y.Y. Li, X.J. Li, S.A. Lv, K. Li, Y.N. Li, Z.R. Gao, J.Y. Feng, C.J. Chen, C. Schaefer, Ascitic
ﬂuid and serum from rats with acute pancreatitis injure rat pancreatic tissues
and alter the expression of heat shock protein 60, Cell Stress Chaperones 15
(2010) 583.
[254] P.L. Hooper, J.J. Hooper, Loss of defense against stress: diabetes and heat shock pro-
teins, Diabetes Technol. Ther. 7 (2005) 204.
[255] I. Kurucz, A. Morva, A. Vaag, K.F. Eriksson, X.D. Huang, L. Groop, L. Koranyi,
Decreased expression of heat shock protein 72 in skeletal muscle of
patients with type 2 diabetes correlates with insulin resistance, Diabetes 51
(2002) 1102.
[256] S. Hu, M.J. Ciancio, M. Lahav, M. Fujiya, L. Lichtenstein, S. Anant, M.W. Musch, E.B.
Chang, Translational inhibition of colonic epithelial heat shock proteins by
IFN-gamma and TNF-alpha in intestinal inﬂammation, Gastroenterology 133
(2007) 1893.
[257] D. Bayramgurler, S.K. Ozkara, R. Apaydin, C. Ercin, N. Bilen, Heat shock proteins 60
and 70 expression of cutaneous lichen planus: comparison with normal skin and
psoriasis vulgaris, J. Cutan. Pathol. 31 (2004) 586.
[258] J. Ojha, R.V. Karmegam, J.G. Masilamoni, A.V. Terry, A.G. Cashikar, Behavioral de-
fects in chaperone-deﬁcient Alzheimer's disease model mice, PLoS One 6 (2011)
e16550.
[259] J. Labbadia, H. Cunliffe, A. Weiss, E. Katsyuba, K. Sathasivam, T. Seredenina, B.
Woodman, S. Moussaoui, S. Frentzel, R. Luthi-Carter, P. Paganetti, G.P. Bates, Al-
tered chromatin architecture underlies progressive impairment of the heat shock
response in mouse models of Huntington disease, J. Clin. Investig. 121 (2011)
3306.
[260] L. Marzec, Z. Zdrojewski, T. Liberek, E. Bryl, M. Chmielewski, J.M. Witkowski, B.
Rutkowski, Expression of Hsp72 protein in chronic kidney disease patients,
Scand. J. Urol. Nephrol. 43 (2009) 400.
[261] F. Cappello, A. Di Stefano, S. David, F. Rappa, R. Anzalone, G. La Rocca, S.E. D'Anna, F.
Magno, C.F. Donner, B. Balbi, G. Zummo, HSP60 and HSP10 down-regulation pre-
dicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pul-
monary disease, Cancer 107 (2006) 2417.
[262] J.G. Xie, J.P. Zhao, C.F. Xiao, Y.J. Xu, S.F. Yang, W. Ni, Reduced heat shock protein 70
in airway smooth muscle in patients with chronic obstructive pulmonary disease,
Exp. Lung Res. 36 (2010) 219.
[263] A.J. Macario, M.E. Conway de, Chaperonopathies by defect, excess, or mistake, Ann.
N. Y. Acad. Sci. 1113 (2007) 178.
[264] M.A. Babizhayev, Y.E. Yegorov, Advanced drug delivery of N-acetylcarnosine
(N-acetyl-beta-alanyl-L-histidine), carcinine (beta-alanylhistamine) and L-carnosine
(beta-alanyl-L-histidine) in targeting peptide compounds as pharmacologi-
cal chaperones for use in tissue engineering, human disease management
and therapy: from in vitro to the clinic, Recent Pat Drug Deliv. Formul. 4
(2010) 198.
[265] G. Nagy, A. Szarka, G. Lotz, J. Doczi, L. Wunderlich, A. Kiss, K. Jemnitz, Z. Veres, G.
Banhegyi, Z. Schaff, B. Sumegi, J. Mandl, BGP-15 inhibits caspase-independent pro-
grammed cell death in acetaminophen-induced liver injury, Toxicol. Appl.
Pharmacol. 243 (2010) 96.
[266] I. Racz, K. Tory, F. Gallyas, Z. Berente, E. Osz, L. Jaszlits, S. Bernath, B. Sumegi, G.
Rabloczky, P. Literati-Nagy, BGP-15— a novel poly(ADP-ribose) polymerase inhib-
itor — protects against nephrotoxicity of cisplatin without compromising its anti-
tumor activity, Biochem. Pharmacol. 63 (2002) 1099.
[267] H.S. Choi, J.Y. Lim, N.J. Chun, M. Lee, E.S. Kim, B. Keum, Y.S. Seo, Y.T. Jeen, S.H. Um,
H.S. Lee, C.D. Kim, H.S. Ryu, D. Sul, The effect of polaprezinc on gastric mucosal pro-
tection in rats with ethanol-induced gastric mucosal damage: comparison study
with rebamipide, Life Sci. 93 (2013) 69.
[268] R. Spiering, Z.R. van der, J. Wagenaar, D. Kapetis, F. Zolezzi, E.W. van, F. Broere,
Tolerogenic dendritic cells that inhibit autoimmune arthritis can be induced by a
combination of carvacrol and thermal stress, PLoS One 7 (2012) e46336.
[269] V.A. Huurman, K. Decochez, C. Mathieu, I.R. Cohen, B.O. Roep, Therapy with the
hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients, Diabetes
Metab. Res. Rev. 23 (2007) 269.
[270] B. Feuerecker, S. Pirsig, C. Seidl, M. Aichler, A. Feuchtinger, G. Bruchelt, R.
Senekowitsch-Schmidtke, Lipoic acid inhibits cell proliferation of tumor cells
in vitro and in vivo, Cancer Biol. Ther. 13 (2012) 1425.
[271] T. Kardon, G. Nagy, M. Csala, A. Kiss, Z. Schaff, P.L. Nagy, L. Wunderlich, G. Banhegyi,
J. Mandl, Inﬂuence of BGP-15, a nicotinic amidoxime derivative, on the vasculariza-
tion and growth of murine hepatoma xenografts, Anticancer Res. 26 (2006) 1023.
[272] P.L. Hooper, L.E. Hightower, P.L. Hooper, Loss of stress response as a consequence of
viral infection: implications for disease and therapy, Cell Stress Chaperones 17
(2012) 647.
[273] X.S. Xu, P.J. Wang, Z.G. Zhao, T.B. Cao, H.B. He, Z.D. Luo, J. Zhong, F. Gao, Z.Y. Zhu, L.
Li, Z.C. Yan, J. Chen, Y.X. Ni, D.Y. Liu, Z.M. Zhu, Activation of transient receptor po-
tential vanilloid 1 by dietary capsaicin delays the onset of stroke in stroke-prone
spontaneously hypertensive rats, Stroke 42 (2011) 3245-U516.
[274] M. Miyata, C. Tei, Waon therapy for cardiovascular disease — innovative therapy
for the 21(st) century, Circ. J. 74 (2010) 617.
[275] J.C. Torres-Narvaez, L.D. Mondragon, E.V. Lopez, I. Perez-Torres, J.A.D. Juarez, J.
Suarez, G.P. Hernandez, Role of the transient receptor potential vanilloid type 1 re-
ceptor and stretch-activated ion channels in nitric oxide release from endothelial
cells of the aorta and heart in rats, Exp. Clin. Cardiol. 17 (2012) 89.
1617Z. Török et al. / Biochimica et Biophysica Acta 1838 (2014) 1594–1618[276] H. Ushijima, K. Tanaka, M. Takeda, T. Katsu, S. Mima, T. Mizushima,
Geranylgeranylacetone protects membranes against nonsteroidal anti-
inﬂammatory drugs, Mol. Pharmacol. 68 (2005) 1156.
[277] P.L. Hooper, P.L. Hooper, M. Tytell, L. Vigh, Xenohormesis: health beneﬁts from an
eon of plant stress response evolution, Cell Stress Chaperones 15 (2010) 761.
[278] A. Panossian, G. Wikman, P. Kaur, A. Asea, Adaptogens exert a stress-protective ef-
fect by modulation of expression of molecular chaperones, Phytomedicine 16
(2009) 617.
[279] R.J. Roberts, C. Agius, C. Saliba, P. Bossier, Y.Y. Sung, Heat shock proteins (chaper-
ones) in ﬁsh and shellﬁsh and their potential role in relation to ﬁsh health: a re-
view, J. Fish Dis. 33 (2010) 789.
[280] J. Wiese, S. McPherson, M.C. Odden, M.G. Shlipak, Effect of Opuntia ﬁcus indica on
symptoms of the alcohol hangover, Arch. Intern. Med. 164 (2004) 1334.
[281] J. Chung, A.K. Nguyen, D.C. Henstridge, A.G. Holmes, M.H. Chan, J.L. Mesa, G.I.
Lancaster, R.J. Southgate, C.R. Bruce, S.J. Duffy, I. Horvath, R. Mestril, M.J. Watt,
P.L. Hooper, B.A. Kingwell, L. Vigh, A. Hevener, M.A. Febbraio, HSP72 protects
against obesity-induced insulin resistance, Proc. Natl. Acad. Sci. U. S. A. 105
(2008) 1739.
[282] B. Literati-Nagy, E. Kulcsar, Z. Literati-Nagy, B. Buday, E. Peterfai, T. Horvath, K. Tory,
A. Kolonics, A. Fleming, J. Mandl, L. Koranyi, Improvement of insulin sensitivity by a
novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized
double-blind clinical trial, Horm. Metab. Res. 41 (2009) 374.
[283] M. Kurthy, T. Mogyorosi, K. Nagy, T. Kukorelli, A. Jednakovits, L. Talosi, K. Biro, Ef-
fect of BRX-220 against peripheral neuropathy and insulin resistance in diabetic
rat models, Lipids Insulin Resist. 967 (2002) 482.
[284] K. Biro, A. Jednakovits, T. Kukorelli, E. Hegedus, L. Koranyi, Bimoclomol (BRLP-42)
ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats, Brain
Res. Bull. 44 (1997) 259.
[285] K. Biro, J. Palhalmi, A.J. Toth, T. Kukorelli, G. Juhasz, Bimoclomol improves early elec-
trophysiological signs of retinopathy in diabetic rats, Neuroreport 9 (1998) 2029.
[286] L. Vigh, P.N. Literati, I. Horvath, Z. Torok, G. Balogh, A. Glatz, E. Kovacs, I. Boros, P.
Ferdinandy, B. Farkas, L. Jaszlits, A. Jednakovits, L. Koranyi, B. Maresca, Bimoclomol:
a nontoxic, hydroxylamine derivative with stress protein-inducing activity and
cytoprotective effects, Nat. Med. 3 (1997) 1150.
[287] E. Szabados, P. Literati-Nagy, B. Farkas, B. Sumegi, BGP-15, a nicotinic amidoxime
derivate protecting heart from ischemia reperfusion injury through modulation
of poly(ADP-ribose) polymerase, Biochem. Pharmacol. 59 (2000) 937.
[288] G. Bardos, K. Moricz, L. Jaszlits, G. Rabloczky, K. Tory, I. Racz, S. Bernath, B. Sumegi,
B. Farkas, B. Literati-Nagy, P. Literati-Nagy, BGP-15, a hydroximic acid derivative,
protects against cisplatin or taxol-induced peripheral neuropathy in rats, Toxicol.
Appl. Pharmacol. 190 (2003) 9.
[289] F. Erdo, S.L. Erdo, Bimoclomol protects against vascular consequences of experi-
mental subarachnoid hemorrhage in rats, Brain Res. Bull. 45 (1998) 163.
[290] D. Zhang, L. Ke, K. Mackovicova, J.J. Der Want, O.C. Sibon, R.M. Tanguay, G. Morrow,
R.H. Henning, H.H. Kampinga, B.J. Brundel, Effects of different small HSPB members
on contractile dysfunction and structural changes in a Drosophila melanogaster
model for atrial ﬁbrillation, J. Mol. Cell. Cardiol. 51 (2011) 381.
[291] B. Farkas, M. Magyarlaki, B. Csete, J. Nemeth, G. Rabloczky, S. Bernath, P.L. Nagy, B.
Sumegi, Reduction of acute photodamage in skin by topical application of a novel
PARP inhibitor, Biochem. Pharmacol. 63 (2002) 921.
[292] A. Jednakovits, I. Kurucz, P.P. Nanasi, Effect of subchronic bimoclomol treatment on
vascular responsiveness and heat shock protein production in spontaneously hy-
pertensive rats, Life Sci. 67 (2000) 1791.
[293] N.L. Lubbers, J.S. Polakowski, C.D. Wegner, S.E. Burke, G.J. Diaz, K.M. Daniell, B.F.
Cox, Oral bimoclomol elevates heat shock protein 70 and reduces myocardial in-
farct size in rats, Eur. J. Pharmacol. 435 (2002) 79.
[294] J. Phukan, Arimoclomol, a coinducer of heat shock proteins for the potential treat-
ment of amyotrophic lateral sclerosis, Idrugs 13 (2010) 482.
[295] K. Xu, X.Y. Sun, B.O. Erokwu, I. Cernak, J.C. LaManna, A heat-shock protein
co-inducer treatment improves behavioral performance in rats exposed to hypox-
ia, Oxygen Transp. Tissue 701 (2011) 313(Xxxii).
[296] Z. Rakonczay, B. Ivanyi, I. Varga, I. Boros, A. Jednakovits, I. Nemeth, J. Lonovics, T.
Takacs, Nontoxic heat shock protein coinducer BRX-220 protects against acute
pancreatitis in rats, Free Radic. Biol. Med. 32 (2002) 1283.
[297] M.E. Toth, S. Gonda, L. Vigh, M. Santha, Neuroprotective effect of small heat shock
protein, Hsp27, after acute and chronic alcohol administration, Cell Stress Chaper-
ones 15 (2010) 807.
[298] S.M. Gehrig, P.C. van der, T.A. Sayer, J.D. Schertzer, D.C. Henstridge, J.E. Church, S.
Lamon, A.P. Russell, K.E. Davies, M.A. Febbraio, G.S. Lynch, Hsp72 preserves muscle
function and slows progression of severe muscular dystrophy, Nature 484 (2012)
394.
[299] B.J. Brundel, L. Ke, A.J. Dijkhuis, X. Qi, A. Shiroshita-Takeshita, S. Nattel, R.H.
Henning, H.H. Kampinga, Heat shock proteins asmolecular targets for intervention
in atrial ﬁbrillation, Cardiovasc. Res. 78 (2008) 422.
[300] K.I. Tanaka, Y. Tanaka, T. Namba, A. Azuma, T. Mizushima, Heat shock protein 70
protects against bleomycin-induced pulmonary ﬁbrosis in mice, Biochem.
Pharmacol. 80 (2010) 920.
[301] T. Asano, K.I. Tanaka, N. Yamakawa, H. Adachi, G. Sobue, H. Goto, K. Takeuchi, T.
Mizushima, HSP70 confers protection against indomethacin-induced lesions of
the small intestine, J. Pharmacol. Exp. Ther. 330 (2009) 458.
[302] A. Sanbe, T. Daicho, R. Mizutani, T. Endo, N. Miyauchi, J. Yamauchi, K. Tanonaka, C.
Glabe, A. Tanoue, Protective effect of geranylgeranylacetone via enhancement of
HSPB8 induction in desmin-related cardiomyopathy, PLoS One 4 (2009).
[303] H. Kitahata, J. Nozaki, S. Kawahito, T. Tomino, S. Oshita, Low-dose sevoﬂurane inhala-
tion enhances late cardioprotection from the anti-ulcer drug geranylgeranylacetone,
Anesth. Analg. 107 (2008) 755.[304] H. Kanemura, K. Kusumoto, H. Miyake, S. Tashiro, K. Rokutan, M. Shimada,
Geranylgeranylacetone prevents acute liver damage after massive hepatectomy
in rats through suppression of a CXC chemokine GRO1 and induction of heat
shock proteins, J. Gastrointest. Surg. 13 (2009) 66.
[305] H. Kitamei, N. Kitaichi, K. Yoshida, A. Nakai, M. Fujimoto, M. Kitamura, K. Iwabuchi,
A. Miyazaki, K. Namba, S. Ohno, K. Onoe, Association of heat shock protein 70 in-
duction and the amelioration of experimental autoimmune uveoretinitis in mice,
Immunobiology 212 (2007) 11.
[306] D.I. Sinn, K. Chu, S.T. Lee, E.C. Song, K.H. Jung, E.H. Kim, D.K. Park, K.M. Kang, M.
Kim, J.K. Roh, Pharmacological induction of heat shock protein exerts neuro-
protective effects in experimental intracerebral hemorrhage, Brain Res. 1135
(2007) 167.
[307] S. Uchida, M. Fujiki, Y. Nagai, T. Abe, H. Kobayashi, Geranylgeranylacetone, a non-
invasive heat shock protein inducer, induces protein kinase C and leads to neuro-
protection against cerebral infarction in rats, Neurosci. Lett. 396 (2006) 220.
[308] T. Ohkawara, J. Nishihira, H. Takeda, T. Katsurada, K. Kato, T. Yoshiki, T. Sugiyama,
M. Asaka, Protective effect of geranylgeranylacetone on trinitrobenzene sulfonic
acid-induced colitis in mice, Int. J. Mol. Med. 17 (2006) 229.
[309] T. Nishida, T. Matsura, J. Nakada, A. Togawa, M. Kai, I. Sumioka, Y. Minami, Y.
Inagaki, Y. Ishibe, H. Ito, Y. Ohta, K. Yamada, Geranylgeranylacetone protects
against acetaminophen-induced hepatotoxicity by inducing heat shock protein
70, Toxicology 219 (2006) 187.
[310] T. Mikuriya, K. Sugahara, T. Takemoto, K. Tanaka, K. Takeno, H. Shimogori, A. Nakai,
H. Yamashita, Geranylgeranylacetone, a heat shock protein inducer, prevents
acoustic injury in the guinea pig, Brain Res. 1065 (2005) 107.
[311] J. Nakada, T. Matsura, N. Okazaki, T. Nishida, A. Togawa, Y. Minami, Y. Inagaki, H.
Ito, K. Yamada, Y. Ishibe, Oral administration of geranylgeranylacetone improves
survival rate in a rat endotoxin shock model: administration timing and heat
shock protein 70 induction, Shock 24 (2005) 482.
[312] Y. Ishii, J.M.K. Kwong, J. Caprioli, Retinal ganglion cell protection with
geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model, In-
vest. Ophthalmol. Vis. Sci. 44 (2003) 1982.
[313] M. Kayama, T. Nakazawa, A. Thanos, Y. Morizane, Y. Murakami, S. Theodoropoulou,
T. Abe, D. Vavvas, J.W. Miller, Heat shock protein 70 (HSP70) is critical for the pho-
toreceptor stress response after retinal detachment via modulating anti-apoptotic
Akt kinase, Am. J. Pathol. 178 (2011) 1080.
[314] M. Unoshima, H. Iwasaka, J. Eto, Y. Takita-Sonoda, T. Noguchi, R. Nishizono, Antivi-
ral effects of geranylgeranylacetone: enhancement of MxA expression and phos-
phorylation of PKR during inﬂuenza virus infection, Antimicrob. Agents
Chemother. 47 (2003) 2914.
[315] Y.Q. Zhao, J.T. Gao, S.H. Liu, Y. Wu, M.T. Lin, M. Fan, Geranylgeranylacetone precon-
ditioning may attenuate heat-induced inﬂammation and multiorgan dysfunction
in rats, J. Pharm. Pharmacol. 62 (2010) 99.
[316] K. Kavanagh, D.M. Flynn, K.A. Jenkins, L. Zhang, J.D. Wagner, Restoring HSP70 deﬁ-
ciencies improves glucose tolerance in diabetic monkeys, Am. J. Physiol.
Endocrinol. Metab. 300 (2011) E894–E901.
[317] A.A. Gupte, G.L. Bomhoff, J.K. Morris, B.K. Gorres, P.C. Geiger, Lipoic acid increases
heat shock protein expression and inhibits stress kinase activation to improve in-
sulin signaling in skeletal muscle from high-fat-fed rats, J. Appl. Physiol. 106
(2009) 1425.
[318] M. Nebbioso, F. Pranno, N. Pescosolido, Lipoic acid in animal models and clinical
use in diabetic retinopathy, Expert. Opin. Pharmacother. 14 (2013) 1829.
[319] K. Ibrahimpasic, Alpha lipoic acid and glycaemic control in diabetic neuropathies at
type 2 diabetes treatment, Med. Arh. 67 (2013) 7.
[320] C.J. Li, L. Lv, H. Li, D.M. Yu, Cardiac ﬁbrosis and dysfunction in experimental diabetic
cardiomyopathy are ameliorated by alpha-lipoic acid, Cardiovasc. Diabetol. 11
(2012).
[321] Y. Lakhtin, Comparative evaluation of short- and long-term treatment of periodon-
titis with alpha-lipoic acid, Georgian Med. News 218 (2013) 19.
[322] G. Mainini, M. Rotondi, K. Di Nola, M.T. Pezzella, S.A. Iervolino, E. Seguino, D.
D'Eufemia, I. Iannicelli, M. Torella, Oral supplementation with antioxidant agents
containing alpha lipoic acid: effects on postmenopausal bone mass, Clin. Exp.
Obstet. Gynecol. 39 (2012) 489.
[323] S. Kapoor, Hepato-protective effects of alpha lipoic acid besides its role in
preventing fatty liver disease, Liver Int. 33 (2013) 162.
[324] T.M. Queiroz, D.D. Guimaraes, L.G. Mendes, V.A. Braga, Alpha-lipoic acid reduces
hypertension and increases baroreﬂex sensitivity in renovascular hypertensive
rats, Molecules 17 (2012) 13357.
[325] M. Astiz, M.J.T. de Alaniz, C.A. Marra, The oxidative damage and inﬂammation
caused by pesticides are reverted by lipoic acid in rat brain, Neurochem. Int. 61
(2012) 1231.
[326] T.H. Lee, J.H. Park, J.D. Kim, J.C. Lee, I.H. Kim, Y. Yim, S.K. Lee, B.C. Yan, J.H. Ahn, C.H.
Lee, K.Y. Yoo, J.H. Choi, I.K. Hwang, J.H. Park, M.H. Won, Protective effects of a novel
synthetic alpha-lipoic acid-decursinol hybrid compound in experimentally in-
duced transient cerebral ischemia, Cell. Mol. Neurobiol. 32 (2012) 1209.
[327] M. Kaya, C.H. Yildirim, K. Kosemehmetoglu, U. Huseyinoglu, H. Erdogan, A.
Akbasak, E. Tasdemiroglu, Alpha-lipoic acid reduces peridural ﬁbrosis after
laminectomy of lumbar vertebrae in rabbits, Acta Neurochir. 154 (2012)
1241.
[328] Y.D. Sun, Y.D. Dong, R. Fan, L.L. Zhai, Y.L. Bai, L.H. Jia, Effect of (R)-alpha-lipoic acid
supplementation on serum lipids and antioxidative ability in patients with
age-related macular degeneration, Ann. Nutr. Metab. 60 (2012) 293.
[329] A. Tahira, U. Saleem, S. Mahmood, F.K. Hashmi, K. Hussain, N.I. Bukhari, B.
Ahmad, Evaluation of protective and curative role of alpha-lipoic acid and
selenium in gentamicin-induced nephrotoxicity in rabbits, Pak. J. Pharm. Sci.
25 (2012) 103.
1618 Z. Török et al. / Biochimica et Biophysica Acta 1838 (2014) 1594–1618[330] M. Li, D.H. Kim, P.L. Tsenovoy, S.J. Peterson, R. Rezzani, L.F. Rodella, W.S.
Aronow, S. Ikehara, N.G. Abraham, Treatment of obese diabetic mice with a
heme oxygenase inducer reduces visceral and subcutaneous adiposity, in-
creases adiponectin levels, and improves insulin sensitivity and glucose toler-
ance, Diabetes 57 (2008) 1526.
[331] M. Li, S. Peterson, D. Husney, M. Inaba, K. Guo, A. Kappas, S. Ikehara, N.G. Abraham,
Long-lasting expression of HO-1 delays progression of type I diabetes in NODmice,
Cell Cycle 6 (2007) 567.
[332] J. Cao, K. Inoue, K. Sodhi, N. Puri, S.J. Peterson, R. Rezzani,N.G. Abraham,High-fat diet
exacerbates renal dysfunction in SHR: reversal by induction of HO-1-adiponectin
axis, Obesity 20 (2012) 945.
[333] A. L'Abbate, D. Neglia, C. Vecoli, M. Novelli, V. Ottaviano, S. Baldi, R. Barsacchi, A.
Paolicchi, P. Masiello, G.S. Drummond, J.A.McClung, N.G. Abraham, Beneﬁcial effect
of heme oxygenase-1 expression on myocardial ischemia–reperfusion involves an
increase in adiponectin in mildly diabetic rats, Am. J. Physiol. Heart Circ. Physiol.
293 (2007) H3532–H3541.
[334] J. Cao, C. Vecoli, D. Neglia, B. Tavazzi, G. Lazzarino, M. Novelli, P. Masiello, Y.T.
Wang, N. Puri, N. Paolocci, A. L'Abbate, N.G. Abraham, Cobalt-protoporphyrin
improves heart function by blunting oxidative stress and restoring NO syn-
thase equilibrium in an animal model of experimental diabetes, Front. Physiol.
3 (2012) 160.
[335] C. Vecoli, J. Cao, D. Neglia, K. Inoue, K. Sodhi, L. Vanella, K.K. Gabrielson, D. Bedja, N.
Paolocci, A. L'Abbate, N.G. Abraham, Apolipoprotein A-I mimetic peptide L-4F pre-
vents myocardial and coronary dysfunction in diabetic mice, J. Cell. Biochem. 112
(2011) 2616.
[336] T.D. Hinds Jr., K. Sodhi, C. Meadows, L. Fedorova, N. Puri, D.H. Kim, S.J. Peterson, J.
Shapiro, N.G. Abraham, A. Kappas, Increased HO-1 levels ameliorate fatty liver de-
velopment through a reduction of heme and recruitment of FGF21, Obesity (Silver
Spring) (2013), http://dx.doi.org/10.1002/oby.20559.
[337] I. Barbagallo, A. Vanella, S.J. Peterson, D.H. Kim, D. Tibullo, C. Giallongo, L. Vanella,
N. Parrinello, G.A. Palumbo, F. Di Raimondo, N.G. Abraham, D. Asprinio, Overex-
pression of heme oxygenase-1 increases human osteoblast stem cell differentia-
tion, J. Bone Miner. Metab. 28 (2010) 276.
[338] A.I. Goodman, R. Olszanecki, L.M. Yang, S. Quan, M. Li, S. Omura, D.E. Stec, N.G.
Abraham, Heme oxygenase-1 protects against radiocontrast-induced acute kidney
injury by regulating anti-apoptotic proteins, Kidney Int. 72 (2007) 945.[339] F.T. Botros, M.L. Schwartzman, C.T. Stier, A.I. Goodman, N.G. Abraham, Increase in
heme oxygenase-1 levels ameliorates renovascular hypertension, Kidney Int. 68
(2005) 2745.
[340] F. Engin, G.S. Hotamisligil, Restoring endoplasmic reticulum function by chemical
chaperones: an emerging therapeutic approach for metabolic diseases, Diabetes
Obes. Metab. 12 (2010) 108.
[341] A. Trapero, P. Gonzalez-Bulnes, T.D. Butters, A. Llebaria, Potent aminocyclitol
glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for
treating Gaucher disease, J. Med. Chem. 55 (2012) 4479.
[342] Y. Suzuki, Chaperone therapy update: Fabry disease, GM1-gangliosidosis and
Gaucher disease, Brain Dev. 35 (2013) 515.
[343] P. Ayala, J. Montenegro, R. Vivar, A. Letelier, P.A. Urroz, M. Copaja, D. Pivet, C.
Humeres, R. Troncoso, J.M. Vicencio, S. Lavandero, G. az-Araya, Attenuation of en-
doplasmic reticulum stress using the chemical chaperone 4-phenylbutyric acid
prevents cardiac ﬁbrosis induced by isoproterenol, Exp. Mol. Pathol. 92 (2012) 97.
[344] E. Seyhun, A. Malo, C. Schafer, C.A. Moskaluk, R.T. Hoffmann, B. Goke, C.H. Kubisch,
Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell dam-
age, and systemic inﬂammation in acute pancreatitis, Am. J. Physiol. Gastrointest.
Liver Physiol. 301 (2011) G773–G782.
[345] S.S. Cao, J.W. Hewett, F. Yokoi, J. Lu, A.C. Buckley, A.J. Burdette, P. Chen, F.C. Nery,
Y.Q. Li, X.O. Breakeﬁeld, G.A. Caldwell, K.A. Caldwell, Chemical enhancement of
torsinA function in cell and animal models of torsion dystonia, Dis. Models Mech.
3 (2010) 386.
[346] G. Dawson, C. Schroeder, P.E. Dawson, Palmitoyl:protein thioesterase (PPT1) inhib-
itors can act as pharmacological chaperones in infantile Batten disease, Biochem.
Biophys. Res. Commun. 395 (2010) 66.
[347] N. Neznanov, A.V. Gorbachev, L. Neznanova, A.P. Komarov, K.V. Gurova, A.V.
Gasparian, A.K. Banerjee, A. Almasan, R.L. Fairchild, A.V. Gudkov, Anti-malaria
drug blocks proteotoxic stress response: anti-cancer implications, Cell Cycle 8
(2009) 3960.
[348] T.W. Mu, D.S.T. Ong, Y.J. Wang, W.E. Balch, J.R. Yates, L. Segatori, J.W. Kelly, Chem-
ical and biological approaches synergize to ameliorate protein-folding diseases,
Cell 134 (2008) 769.
[349] T. Sauer, M. Patel, C.C. Chan, J. Tuo, Unfolding the therapeutic potential of chemical
chaperones for age-related macular degeneration, Expert Rev. Ophthalmol. 3
(2008) 29.
